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ABSTRACT 
This thesis focuses on the discovery of full-length mRNA transcripts in Bos 
taurus spermatozoa. The primary aim of this study is to identify and validate full-
length mRNA primarily from RNA-Sequencing of bovine spermatozoa. The 
secondary aim is to determine if full-length spermatozoal transcripts are delivered to 
the oocyte at fertlilization, allowing for future studies to track their inheritance from 
paternal sources to the embryo. The main hypothesis of this thesis is that full-length 
mRNA transcripts exist within the spermatozoal transcript profile in Bos taurus. The 
secondary hypothesis is that if spermatozoal mRNA is functional after fertilization, 
then full-length transcripts should be present in the early stage embryo. To examine 
these hypotheses, this thesis is divided into three main chapters.  
The first is a literature review, discussing the process of spermatogenesis, the 
unique properties of spermatozoal mRNAs, including some hypothesized functions of 
spermatozoal mRNAs. A summary of a new technique, RNA-Sequencing, will be 
discussed in this review as well as comparisons to previous literature techniques for 
identifying mRNA transcripts of interest.  
The second chapter is the manuscript published in the journal Biology of 
Reproduction in January 2013, co-first-authored by Christopher Card. This manuscript 
uses the technique RNA-Seq to examine the transcript profile of nine Bos taurus bulls, 
and highlights several transcripts of interest for further study. This study found 6,166 
total transcripts, and performed Gene Ontology analysis of the transcripts to categorize 
them into functional categories for further examination, the top most category of 
interest being translation.  
  
 
The third chapter of this thesis is a manuscript in preparation, formatted for 
submission to the journal of Molecular Reproduction and Development. This 
manuscript evaluates twenty four target mRNA transcripts to see if they are full-
length. These transcripts were identified through four main methods: their location on 
the Y chromosome, their high expression in the RNA-Seq data set from chapter 2, 
their presence in Gene Ontology categories of interest from chapter 2, and their 
discovery from previous literature studies. Sixteen transcripts are found to be full-
length, eight are degraded, and four have alternative polyadenylation ends.  
In conclusion, several full-length transcripts were found in this study, which 
have the potential to create functional proteins downstream in the fertilized oocyte. 
Several transcripts were also proved to be degraded in the mature spermatozoa. This 
has confirmed the need for this type of study, and elucidates new transcript targets for 
further research to pursue.  
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CHAPTER 1: LITERATURE REVIEW 
I. Introduction 
The presence of messenger RNA (mRNA) in transcriptionally-silent 
spermatozoa was initially discovered in 1989 (Pessot et al. 1989).  While most 
information is known about spermatozoa creation and spermatozoal DNA, little is 
known about the mRNAs contained within spermatozoa and their function. The 
primary focus of this thesis is the composition of the spermatozoal mRNA and the 
potential contributions of the spermatozoa to the oocyte at fertilization. Specifically of 
interest to this study is whether or not the mRNAs contained within spermatozoa are 
functional, or simply degraded remnants. A summary of what RNAs are present in 
spermatozoa is presented here, as well as several hypotheses as to the functions that 
these spermatozoal mRNAs might serve. Following discussion of the spermatozoal 
RNAs, this review will examine a new method for identifying RNA transcripts of 
interest, called RNA-Seq, which was used for the Chapter 2 Biology of Reproduction 
publication. This will include a comparsion with previous methods for identifying 
RNAs.  This review will conclude with the hypotheses and aims of this study. 
II. Gametogenesis 
 Both males and females create specialized reproductive cells through the 
process of gametogenesis.  Many mechanisms are shared between spermatogenesis 
(the generation of male spermatozoa) and oogenesis (generation of female oocytes). 
Foremost, diploid stem cells in both males and females divide through mitosis and 
meiosis I and II into four haploid cells. In spermatogenesis, all four haploid cells 
mature into individual spermatozoa. In oogenesis, three of the four haploid cells form 
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polar bodies that are discarded as the oocyte matures, until it contains only a single 
haploid nucleus. Meiosis also increases the genetic variation between the haploid cells 
through homologous recombination (Schlecht and Primig 2003; P.L.Senger 2005). 
Similar hormonal mechanisms are also used for spermatogenesis and oogenesis, with 
gonadotropin releasing hormone and lutenizing hormone acting as triggers for germ 
cell release in both processes (Holstein et al. 2003; P.L.Senger 2005). 
Despite these basic similarities between spermatogenesis and oogenesis, the 
two processes achieve their reproductive goals through two very different methods. 
The main difference is that only males have a self-renewing system, which enables 
them to create much greater numbers of gametes compared to females (Holstein et al. 
2003), discussed below. Unlike spermatozoa, the stem cells that create oocytes are 
incapable of self-renewing post-natally (Kocabas et al. 2006). For an oocyte to mature, 
they have to halt cell death, activate maternal transcription, unpack paternal DNA, and 
then kick-start embryo development (Potireddy et al. 2006). Once the spermatozoa 
fuse with the oocyte, the spermatozoa may be able to assist the oocyte with some of 
these functions. The maternal contribution produces a limited number of oocytes, but 
invests more energy into the production of oocytes with large biomass (Hayward and 
Gillooly 2011). In contrast, the paternal strategy focuses on the production of massive 
quantities of spermatozoa.  
II. A. Spermatogenesis 
Spermatogenesis is the process that spermatogonial stem cells undergo in the 
testis to mature into functional spermatozoa which is supported by Sertoli nurse cells 
(Figure 1; Petersen et al., 2006; Zhang et al., 2012),) To compensate for the need to 
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make large quantities of spermatozoa, males use a self-renewing stem cell system to 
allow for production of spermatozoa from sexual maturity up until death. To this end, 
spermatozoa develop from a group of stem cells in the testis, which are capable of 
self-renewal through continuous mitosis (Holstein et al. 2003).  The developing germ 
cells then enter meiosis I and II, now called spermatocytes, and, after a final 
homologous recombination event, become haploid round spermatids (Iguchi et al. 
2006).   
During the early round spermatid stage of the second meiosis, a significant 
increase of transcription and translation also occurs, depositing all the mRNAs the 
mature spermatozoa will maintain (Braun 2000; Eddy 2002; Holstein et al. 2003). 
From this point forward in spermatogenesis, the spermatids become transcriptionally 
silent and cease making mRNAs, although new proteins are later produced for the 
morphological changes necessary for mature spermatozoa formation. Several 
transcripts that remain in round spermatid are modified through post-transcriptional 
mechanisms in the 5’ and 3’ untranslated regions to hold them in an inactive state for 
later translation (Braun 1998). This is regulated by accessory proteins such as Tarbp2 
(Braun 2000), and is known to be used on the transcripts PRM1 and PRM2 (Mali et al. 
1989).  
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Figure 1: Spermatogenesis 
The final differentiation of the developing spermatozoa cell occurs as the 
morphological changes create the spermatozoa head and tail. During this 
differentiation, round spermatids undergo a final process called cyto-differentiation, 
where the cells condense their nucleus, form an enzyme cap to help with fertilization, 
and develop the motor flagella needed for locomotion (Holstein et al. 1988). As the 
cytoplasm is lost in this elongating spermatid, the spermatozoa lose the ability to 
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translate mRNAs into proteins, but the population of silenced mRNAs remain. Some 
silenced transcripts, from the elongating spermatid stage, are translated at this stage of 
development in order create new proteins to facilitate head and tail development. The 
final packing of the DNA occurs as spermatogenesis concludes, and the spermatozoa 
are released into the seminiferous tubule for their journey through the female 
reproductive tract (Dadoune et al. 2004).  
Throughout the process of spermatogenesis, several unique mechanisms are 
utilized to regulate temporal and quality control of the spermatozoal mRNAs. 
Transcriptional silencing, discussed above, is one of the standard mechanisms used to 
regulate timing of mRNA transcript use during spermatogenesis (Braun 2000). Around 
the same time that selective mRNAs are being silence, the developing spermatozoa 
also performs DNA-repair and apoptosis to ensure quality of the mature spermatozoa 
(Smirnova et al. 2006). Prior to nuclear condensation ubiquitin-mediated proteolysis 
removes selective proteins from the cell, is responsible for replacing histones with 
sperm-specific protamines (Sutovsky 2003), and degrades selective mRNAs in the 
developing embryo (Thompson et al. 2003). The exact percentage of spermatozoa 
mRNAs that are degraded is unknown. When these regulatory mechanisms 
malfunction, the spermatozoal quality and fertility decrease (Foote 2003).  
III. What is spermatozoal mRNA? 
III. A. Composition 
 The focus of this thesis is investigating the existence of full-length transcripts 
in bovine spermatozoa thus providing more evidence that spermatozoa mRNAs may 
be functional. Spermatozoa carry not only paternal DNA, but also paternal RNAs to 
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the oocyte at fertilization, but no previous studies have examined whether these 
mRNAs are full-length, a prerequisite for functionality as a protein. Finding the 
functionality of these transcripts is particularly interesting since spermatozoa are 
translationally silent at maturity, indicating that they are incapable of utilizing these 
mRNAs themselves (Miller and Ostermeier 2006).  
 Although the pool of spermatozoal RNAs is small, it contains a variety of 
different RNAs, including: mRNAs, rRNA, and siRNAs (Boerke et al. 2007). The 
function of some spermatozoal RNAs are known. For example, selective rRNA 
transcripts for ribosome proteins are retained or degraded through specific cleavage in 
the spermatozoa (Johnson et al. 2011b). The lack of complete ribosomes is one of the 
reasons why translation is not possible in the mature spermatozoa. Another type of 
RNAs found in spermatozoa is siRNAs, which have been demonstrated to be stable all 
the way until the activation of the embryonic genome (Kono et al. 2004). In addition, 
sperm-derived siRNAs have been shown to imprint on male germ cells (Reik and 
Walter 2001), and can modulate embryonic gene expression (Mao et al. 2002).  
Spermatozoal microRNAs such as microRNA-34c are also known to impact 
functionality in embryo development by regulating the first cellular division of the 
embryo (Liu et al. 2012).  
     This thesis focuses on the population of mRNAs in spermatozoa. The precise 
number of mRNAs contained per spermatozoa is unknown, but has been estimated to 
be approximately 3000-7000 transcripts (Ostermeier et al. 2002; Gilbert et al. 2007; 
Das et al. 2010), or approximately 5-10 fg per spermatozoa. This minimal amount of 
mRNA per spermatozoa makes detection of the mRNA difficult (Boerke et al. 2007). 
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The location of the spermatozoal mRNAs may provide a clue to the function.  While 
the majority of spermatozoal mRNAs are located in the nucleus, a limited number of 
mRNAs are located in other areas. For example, SP17 is expressed in the flagellar 
fibrous sheath (Chiriva-Internati et al. 2009). The protein made by the transcript 
SMCY is present on the surface of spermatozoa (Yao et al. 2010a). The mRNAs 
located on the outside of the nucleus may be more likely to have an impact on the act 
of fertilization or spermatozoa survival, rather than on embryogenesis, but it is not 
known if and where they are translated into protein.  
III. B. Potential Functions of Spermatozoal mRNA 
It was originally thought that the mRNAs in spermatozoa were just a remnant 
of the spermatogenesis process, but newer evidence supports the translation and 
function for these silenced mRNAs during fertilization and early embryonic 
development. The presence of regulatory mechanisms for mRNA timing also lends 
credence to the idea that the maturing spermatozoa may in fact be preserving them for 
later use.  
There are a variety of hypothesized functions for spermatozoal mRNAs. 
Spermatozoa from several species have been examined using microarrays, although 
the most common are humans (Ostermeier et al. 2005; Chalmel et al. 2007; García-
Herrero et al. 2010), rodents (Smirnova et al. 2006; Chalmel et al. 2007; Yao et al. 
2010b; Liu et al. 2012), and bulls (Gilbert et al. 2007; Bissonnette et al. 2009; 
Vigneault et al. 2009; Feugang et al. 2010).  
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Some common spermatozoal transcripts among these species include PRM1, 
CLU, PGK2, AKAP4, PRM2, H2AFZ, COX7A2, and DNMT1. Several of the functions 
hypothesized from these mRNAs are discussed below, and largely focus on mRNA 
functions in fertilization, embryogenesis, or as a tool for fertility assays.  
III.B.1. Spermatozoal survival in the female reproductive tract and fertilization 
It is hypothesized that the translation of some spermatozoa mRNAs facilitate 
spermatozoa maturation in the female tract, known as capacitation, rather than 
impacting the embryo’s development. By assisting with spermatozoa survival and the 
act of fertilization, these spermatozoa may influence fertility without ever impacting 
the embryo directly (Killian 2012). As stated previously, mature spermatozoa lack the 
cytoplasmic ribosomes to translate spermatozoal mRNAs but limited data suggest 
translation may occur in the spermatozoa mitochondria. Interestingly, there is some 
limited evidence that some spermatozoal nuclear-encoded mRNAs are translated in 
the mitochondria in the tailpiece of the spermatozoa, only occurring right before 
fertilization and right after the spermatozoa undergo capacitation (Gur and Breitbart 
2008).   Other spermatozoal proteins such as CRISP2, CCT8, and PEBP1 may assist 
with sperm-egg fusion during fertilization although it is not yet known if the 
spermatozoal transcripts themselves are also translated and contribute to this role in 
capacitation and fertilization (Arangasamy et al. 2011).  
III.B. 2. Early embryogenesis 
After the introduction of the paternal genome at fertilization, there is a lag time 
before the activation of the embryonic genome when the maternal genome maintains 
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activity in the early zygote.  In Bos taurus, the transition from maternal gene 
expression to zygotic gene expression occurs approximately 62 hours after fertilization 
(Memili and First 2000). Prior to this transition, the oocyte is responsible for mRNA 
and protein synthesis, helping with both maternal and paternal gene organization, and 
aiding the fusion of two pronuclei to form the zygotic nucleus (Potireddy et al. 2006). 
Due to this lag time in the activation of the embryonic genome, it has been 
hypothesized that spermatozoal mRNAs might function before activation of the 
embryonic genome (Ostermeier et al. 2002). This is supported by experiments that 
demonstrated that specific spermatozoal mRNAs are transferred to the oocyte at 
fertilization including clusterin (CLU), protamine 2 (PRM2), protamine 1 (PRM1), and 
DDX3Y (Ostermeier et al. 2002; Swann et al. 2006; Kempisty et al. 2008a) although a 
specific function for these spermatozoal transcripts has not been determined, and 
several are likely degraded rapidly upon entering the oocyte.  
III. B.2.a. Oocyte activation 
One of the only definitive functions for spermatozoal mRNA is oocyte 
activation at fertilization, caused by the specific transcript PLCZ1. PLCZ1 triggers 
calcium oscillations in the oocyte. This activation occurred both when the RNA was 
injected into the oocyte (Saunders et al. 2002; Rogers et al. 2004), and when the 
protein was injected (Swann et al. 2006). The egg activation causes the oocyte to 
finish maturing and triggers the transition to embryonic genome control (Boerke et al. 
2007). This transcript appears to be highly conserved, occurring in animals from 
drosophila to humans (Fischer et al. 2012). 
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III. B.2.b. Protamines: chromatin repackaging & regulation 
During spermatogenesis, histones are replaced by transition proteins and then 
finally by protamines. Protamines PRM1 and PRM2 are responsible for replacing 
histones to package DNA at the end of spermatogenesis, so regulation of these specific 
transcripts will have a large impact on how chromatin gets packaged (Mali et al. 
1989). The manner in which genes are packaged depends on how they might be used, 
with selective components of the DNA remaining loosely wound for access by 
translational machinery (Miller et al. 2005; Miller and Ostermeier 2006; Carrell and 
Hammoud 2010; Arangasamy et al. 2011; Ellis et al. 2011; Johnson et al. 2011b; 
Hamatani 2012). Spermatozoal mRNAs might assist with this organization through 
the use of the mRNAs as a structural component, acting to expose areas of DNA and 
preventing them from being wrapped up as tightly in the mature spermatozoa (Wykes 
et al. 1997).  
Aside from repackaging the spermatozoal DNA, the protamines are 
responsible for temporal control of protein synthesis in developing spermatozoa. This 
is accomplished by creating the protamines early in spermatogenesis, and then 
silencing them until they are needed for nuclear condensation at the end of 
spermatogenesis (Braun 2000).  PRM1 is highly conserved and has been found in 
spermatozoa of mice (Eddy 2002; Rassoulzadegan et al. 2006; Johnson et al. 2011a), 
cows (Gilbert et al. 2007; Lalancette and Miller 2008; Bissonnette et al. 2009; 
Feugang et al. 2010; Hecht et al. 2010; Ganguly et al. 2012; Card et al. 2013), humans 
(Ziyyat et al. 1999; Avendaño et al. 2009; Carrell and Hammoud 2010; Johnson et al. 
2011a; Hamatani 2012; Jodar et al. 2012), and marmosets (Hecht et al. 2010).  Of the 
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transcripts previously studied, protamine 1 (PRM1) is also one of only a few that have 
been investigated in multiple species, and proven to be transferred to the oocyte in Bos 
taurus (Hecht et al. 2010). Although PRM1 mRNA is transferred from the 
spermatozoa to the oocyte at fertilization, a functional role is unlikely because related 
PRM2 has been demonstrated to be rapidly degraded in the oocyte (Avendaño et al. 
2009). The ability to detect PRM1 in the oocyte is likely due to its critical function in 
spermatozoa maturation, which leaves many copies of the PRM1 and PRM2 
transcripts untranslated in the spermatozoa after maturation.   
Despite PRM1 likely being a non-functional spermatozoal mRNA in the 
oocyte and embryo, it has a potential for use in a fertility assay that represents gene 
expression during spermatogenesis (see Fertility section below), even if found in a 
degraded state (Gilbert et al. 2007).  Protamines are also useful candidates for tracking 
mRNA inheritance patterns because they are sperm-specific (Kempisty et al. 2008b; 
Hecht et al. 2010).  
III. B. 2. c. Oocyte meiotic division 
 One way that spermatozoal mRNAs may impact embryogenesis is through 
control of the cell cycle, such as preventing or promoting the timing of cell divisions. 
For example, the microRNA-34c has been demonstrated to be responsible for the first 
cleavage of the embryo in mice. MicroRNA-34c is also known to be carried by the 
spermatozoa rather than the oocyte (Liu et al. 2012). This demonstrates that at a basic 
level, spermatozoa determine the timing of development.  
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Other transcripts directly regulate the cell cycle, such as CKS2 that is involved 
in the MI anaphase transition in the cell cycle. Mutations present in this gene are 
responsible for sterility in both men and women (Donovan and Reed 2003).  Cell cycle 
regulation is very important in early embryo development because it helps to 
determine when the embryo will overtake its own gene expression and cease using 
paternal or maternal sources of mRNAs and proteins (Hecht et al. 2009).  
III. B. 2. d. Embryo imprinting 
 In reproduction, an eternal arms race exists between which copy of a gene will 
be used by the embryo: the maternal copy or the paternal copy? A large portion of this 
is controlled by a process called imprinting, which marks which copy of the allele to 
use by methylating the unused gene copy (Jenkins and Carrell 2012). This process is 
thought to be partially controlled by spermatozoal antisense RNAs, which act to 
maintain and protect the paternal copies of genes from degradation mechanisms as 
they enter the oocyte. The RNAs are hypothesized to work through the formation of a 
transcriptional silencing complex, which tags paternal DNA for imprinting in the 
oocyte (Miller and Ostermeier 2006).  
III. B. 2. e. Epigenetic influences 
There are many different ways that spermatozoal mRNAs might help the 
earliest stages of fertilization to establish and maintain the paternal genome (Miller et 
al. 2005). This touches on the idea of selfish genes: that the mRNAs of the father may 
be acting to further paternal interests, while maternal mRNAs compete against them. 
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This may also explain why certain transcripts are expressed highly and selectively in 
spermatozoa versus oocytes (Kleene 2005). 
An expanding field of interest as to the mechanism of these changes is the field 
of epigenetics. Epigenetic changes are changes in the genetics or phenotype resulting 
from modifications other than to the underlying DNA. This is to say that epigenetics 
are post-processing modifications made to DNA, mRNAs, and proteins that affect 
areas other than the DNA coding (see Figure 2 below). Epigenetic modifications have 
been linked to cases of male infertility, and commonly occur through histone 
modifications and DNA methylation (Carrell and Hammoud 2010). RNAs are partially 
responsible for the control of this DNA methylation, with Kit mRNA knockouts 
resulting in heritable epigenetic changes in mice offspring, although the precise 
mechanism of change is unknown (Rassoulzadegan et al. 2006).  
III. B. 2. f. Regulating proper embryo development 
After fertilization, some transcripts from spermatozoa may still exist that can 
impact the developing embryo. Transcripts for the proteins HLA-E, PSGI, and PRM2 
are found in spermatozoa from fertile men have been demonstrated to have an impact 
on embryo implantation and development, although the length of duration of the 
action is limited to approximately 24 hours after fertilization, at which point the first 
polar body is released (Avendaño et al. 2009).  
Another spermatozoal transcript that is delivered to the oocyte at fertilization is 
DDX3Y.  DDX3Y is a DEAD-box RNA helicase, and is one of 33 total genes found 
on the Y chromosome (Marshall Graves 2000), which also has an X chromosome 
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homolog (Vong et al. 2006). The X homolog of DDX3Y also shares in similar 
functions, but it has been demonstrated that when the X-encoded isoform is mutated, 
that DDX3Y is capable of rescuing some of the functionality for the embryo 
(Sekiguchi et al. 2004). DDX3Y is located in a known azoospermia region on 
spermatozoa, a region known for causing infertility in the spermatozoa when damaged 
(Session et al. 2001; Vong et al. 2006). In mature spermatozoa, DDX3Y is localized to 
the post-acrosomal region of sperm, and injection of as-DDX3Y into the oocyte 
nucleus has been correlated with decreased embryo development rates (Yao et al. 
2010b). 
III. B. 3. Spermatozoal mRNA use as a fertility assay 
Assessing fertility of spermatozoa has been limited to tests of morphology, 
motility, and concentration (Lalancette and Miller 2008; Feugang et al. 2010). These 
measurement of spermatozoa function are incapable of predicting whether the 
spermatozoa possess the ability to survive the female reproductive tract, fertilize an 
egg, or even produce a viable embryo (Sutovsky 2003; Bissonnette et al. 2009). Due to 
this problem, finding more quantitative measures of fertility is highly desirable. By 
identifying spermatozoal mRNAs, we are not only provided with information about 
their potential function, but may also find uses for them as diagnostic measures of 
fertility for individuals. The mRNAs produced by an individual are consistent from 
ejaculate to ejaculate, and vary between individuals, making them a stable target for a 
fertility assay (Das et al. 2010). In addition, the amount of individual transcripts 
CRISP2, CCT8, and PEBP1 has been correlated with relative fertility of individual 
bulls (Arangasamy et al. 2011). The efficiency with which PRM1 proteins package 
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DNA has also been shown to impact fertility, and is differentially expressed in fertile 
versus infertile bulls (Carrell and Hammoud 2010; Feugang et al. 2010; Ganguly et al. 
2012; Jodar et al. 2012). The spermatozoal mRNAs may therefore be used as a 
snapshot of fertility, providing better diagnostic tools to examine infertility (Dadoune 
et al. 2004; Ostermeier et al. 2005; Lalancette et al. 2008).   
As previously discussed, many of the mRNAs in spermatozoa are degraded or 
will be degraded rapidly in the oocyte. However, even incomplete mRNA transcripts 
may be used as a snapshot of fertility, and also as a predictor of infertility (Dadoune et 
al. 2004; Ostermeier et al. 2005; Lalancette et al. 2008). This is because the mRNAs 
are deposited in spermatozoa at a single timepoint, so they reflect how efficiently the 
spermatozoa were developing at that point. Many of the mutations in spermatozoa that 
would render them incapable of fertilization occur around this time (Miller and 
Ostermeier 2006). A few studies have indicated that degraded mRNAs are specific to 
an individual; they may serve as a useful fertility assay to measure relative fertility 
(Suri 2004; Feugang et al. 2010; Park et al. 2012). This is particularly useful for 
mutations that alter the genetics and transcript profiles without altering the general 
phenotype or motility (Foote 2003). For example, the calmegin gene is required for 
allowing spermatozoa to progress past the uterotubal junction in the female 
reproductive tract, making knockouts of the calmegin gene infertile. However, these 
knockouts fail to express any morphological or motility abnormalities, so they would 
not be detected using standard fertility assays (Yamagata et al. 2002).  
IV. Full-Length mRNA Transcripts 
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While some specific spermatozoal transcripts have been identified, 
functionally depends on the presence of intact, full-length transcripts that can be 
translated into proteins either in the spermatozoa or in the early stage embryo.  
Spermatozoal transcript profile methods, primarily microarray studies, have so far 
only identified the presence of transcripts but have not designated between whether 
the mRNA transcripts are full-length or degraded remnants of spermatogenesis.  If 
spermatozoal mRNA is functional after fertilization, then full-length transcripts should 
exist within the spermatozoa transcript profile.  
 
Figure 2: Diagram of a full-length mRNA transcript. UTR= Untranslated Region 
 
A full-length transcript requires several parts to be translated into a functional 
protein (Figure 2). The coding region provides the nucleotide sequences to be 
translated into protein while much of the protein regulation is done by the UTRs, the 
5’ cap and 3’ poly(A) tail. At the 5’ end, a modified guanine cap is responsible for 
recognition of the mRNAs by ribosomes, providing the attachment for their translation 
and determining the efficiency with which mRNAs will be translated (Parker and 
Sheth 2007). The cap also influences the survival of the mRNA, by stabilizing it 
against degradation (Gallie 1991).   
The untranslated regions (UTRs) flanking both sides of the coding region 
contain regulatory elements that control gene expression including post-transcriptional 
gene expression in the 3’UTR.  Regulatory elements in the UTR impact degradation 
by setting the location of the stop codon that completes the mRNA, by controlling the 
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tertiary structure of the protein being formed, and by regulating decay of the mRNA 
(Isken and Maquat 2007).  The 3’ UTR can also be modified or lengthened, a process 
called alternative polyadenylation (Danckwardt et al. 2008). These modifications can 
lead to several different transcript isoforms , which may be expressed simultaneously 
within a given individual’s transcriptome (Kleene 2005). At the end of the mRNA, the 
3’ end poly(A) tail also contributes to the rate of mRNA degradation, and is the site of 
many of the epigenetic changes that occur to spermatozoal mRNAs (Rassoulzadegan 
et al. 2006). The new method of global transcriptome discovery, RNA-Seq, will 
facilitate the identification of full-length transcripts, and can detect many of the 
modifications to known transcripts discussed above.  
V. RNA-Seq: a global transcript discovery method 
The identification of full-length transcripts in spermatozoa is essential to 
identify candidate transcripts for further analysis of function.  As mentioned 
previously, studies to date have use methods that only detect a small portion of a 
transcript but do not reveal if full-length transcripts are present. For example, 
microarrays are a hybridization-based method that can detect the presence and amount 
of transcript but is limited to known transcripts. An incomplete transcriptome for 
sperm, oocytes, and embryos has been previously reported by microarrays in humans 
(Ostermeier et al. 2005; Chalmel et al. 2007; García-Herrero et al. 2010), rodents 
(Potireddy et al. 2006; Smirnova et al. 2006; Chalmel et al. 2007; Yao et al. 2010b; 
Liu et al. 2012), and bulls (Misirlioglu et al. 2006; Gilbert et al. 2007; Bissonnette et 
al. 2009; Thelie et al. 2009; Vigneault et al. 2009; Feugang et al. 2010).  
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RNA-sequencing (RNA-Seq) is a newer high-throughput method that 
sequences an entire transcriptome in situ, which removes the constraints of only 
searching for known transcripts and can sequence the entire length of a transcript. This 
allows for the discovery of novel transcripts (Wang et al. 2009; Mamo et al. 2011; 
Driver et al. 2012). Additionally, RNA-Seq provides quantitative expression levels by 
assessing the number of sequencing reads mapping to a specific transcript. In RNA-
Seq, mRNA is fragmented, sequenced in situ into reads then aligns reads to a 
reference genome (Figure 3), or assembles them de novo.  
 
Figure 3: RNA-Seq Methodology A) Transcripts are fragmented into many pieces, 
with adaptors attached to both ends, adaptors shown in blue and red. B) Example of 
RNA-Seq read alignment to a reference genome after sequencing. Exons depicted are 
categorized into three major categories, shown at bottom.  
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Using a reference genome allows for improved annotation of the transcripts, 
and comparison of expression levels between tissues (Wang et al. 2009).  
Additionally, RNA-Seq is capable of identifying transcripts with novel exons, unusual 
isoforms, and alternatively polyadenylated ends (Cui et al. 2010; Driver et al. 2012). 
This allows for a thorough survey of the RNA population, although PCR verification 
is required to confirm all novel discoveries. Only a few studies have used RNA-Seq 
for oocytes, embryos, and testis (Ameur et al. 2011; Esteve-Codina et al. 2011), but 
the manuscript presented in this thesis (Card and Anderson et al., 2013) is the first to 
report the spermatozoal transcript profile using RNA-Seq for any species.  
VI. Hypotheses  
1. Full-length transcripts exist within the spermatozoal transcript profile.  
2. If spermatozoal mRNA is functional after fertilization, then full-length 
transcripts will be found in the early embryo. 
VII. Aims 
The primary aim of this study is to identify and validate full-length mRNA 
primarily from RNA-Sequencing of bovine spermatozoa. The secondary aim is to 
determine if full-length spermatozoal transcripts are delivered to the oocyte at 
fertlilization, allowing for future studies to track their inheritance from paternal 
sources to the embryo.  
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Abstract 
     Ejaculated bovine spermatozoa retain a pool of RNAs that may have a function in 
early embryogenesis and be used as predictors of male fertility.  The bovine 
spermatozoal transcript profile remains incomplete because previous studies have 
relied on hybridization-based techniques, which evaluate a limited pool of transcripts 
and cannot identify full-length transcripts. The goal of this study was to sequence the 
complete cryopreserved bovine spermatozoal transcript profile using Illumina RNA-
Seq.  Spermatozoal RNA was pooled from nine bulls with conception rate (CR) scores 
ranging from -2.9 to 3.5 and confirmed to exclude genomic DNA and somatic cell 
mRNA. After selective amplification of polyA+ RNA and high-throughput sequencing, 
6,166 transcripts were identified via alignment to the bovine genome (UMD 
3.1/bosTau6). RNA-Seq transcript levels (n=9) were highly correlated with qPCR 
copy number (r2=0.9747). The bovine spermatozoal transcript profile is a 
heterogeneous population of degraded and full-length predominantly nuclear-encoded 
mRNAs. Highly abundant spermatozoal transcripts included PRM1, HMGB4 and 
mitochondrial-encoded transcripts.  Full-length transcripts comprised 66% of the top 
368 transcripts (FPKM>100) and the full-length amplification or 5’ and 3’ exons were 
confirmed for some transcripts. In addition to the identification of transcripts not 
previously reported in spermatozoa, several known spermatozoal transcripts from 
various species were also found. Gene ontology analysis of the top 368 spermatozoal 
transcripts revealed that translation was the most predominant biological process 
represented. This is the first report of the spermatozoal transcript profile in any species 
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using high-throughput sequencing, supporting the presence of mRNA in spermatozoa 
for further functional and fertility studies.  
 
Introduction 
     In addition to delivering the paternal genome to the oocyte at fertilization, 
ejaculated spermatozoa retain a pool of RNAs, containing mRNAs, rRNAs and short 
non-coding RNAs [1-4].  Spermatozoal antisense RNAs   epigenetically regulate early 
embryonic development and have a structural role in maintaining histone-bound 
spermatozoa chromosomal regions [3-6]. Although the complete spermatozoal mRNA 
profile is not known, spermatozoa contain at least 3,000-7,000 mRNAs with 
predominantly short fragments, probably indicative of a predominance of degraded 
RNA [7-9]. Individual spermatozoal transcripts that have been identified include 
mRNAs for ribosomal proteins, mitochondrial proteins, protamines, and proteins 
involved in signal transduction and cell proliferation [7-12]. The hypothesized 
function of the spermatozoal transcripts in transcriptionally-silent spermatozoa is 
currently unknown although spermatozoa-derived mRNAs, including PRM1, PRM2, 
PSG-1, CLU, HLA-E, DBY and PLCZ1, can be detected in embryos post-fertilization 
suggesting a role for spermatozoal mRNAs in the zygote [13-18].  However, only 
translation of PLCZ1 has been demonstrated in embryos and many of these 
spermatozoal transcripts are rapidly degraded in the embryo rendering them non-
functional [15-18].  Some spermatozoal transcripts may be translated in the 
mitochondria during capacitation [19].  Additionally, the diagnostic potential of the 
total spermatozoal RNA population as a snapshot of spermatogenic gene expression is 
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emerging.  Individual transcripts are stably regulated within and between individual 
males and perturbation of the ubiquitin-proteosome pathway during spermatogenesis 
can be detected in spermatozoal RNA making this a promising area for male fertility 
assay development [20-23]. 
     The bovine spermatozoal transcript profile remains incomplete because previous 
studies have relied on hybridization-based techniques, which evaluate a limited pool 
of transcripts and do not provide information about full-length transcripts [7, 9, 10, 24, 
25].  In contrast, RNA-Sequencing (RNA-Seq), based on high-throughput sequencing 
technology, is revolutionizing our understanding of transcriptomics by enabling 
sequencing of complete transcript profiles, including full-length mRNAs and 
identifying novel splicing junctions and exons [26, 27]. Also unique to this direct 
sequencing, absolute quantification of a broad range of expression levels across 
transcripts can be obtained.  High-throughput sequencing of the total RNA in human 
spermatozoa has focused on rRNA and small non-coding RNA populations but the 
complete mRNA profile has not been reported [2, 4].  
     We hypothesize that the transcript profile of cryopreserved bovine spermatozoa can 
be directly sequenced using RNA-Seq. Over 6000 spermatozoal transcripts were 
sequenced with this approach and a heterogeneous population of degraded and full-
length mRNAs was identified.  Previously reported spermatozoal transcripts were 
confirmed while a number of transcripts not previously found in spermatozoa of any 
species have also been identified including HMGB4, GTSF1, and CKS2.   This is the 
first study to date to utilize RNA-Seq to sequence the spermatozoal mRNA population 
and report full-length transcripts for any species.  
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Materials and Methods 
Spermatozoa Samples 
     Cryopreserved spermatozoa from  Holstein bulls with conception rate (CR) scores 
ranging from -2.9 to 3.5 were obtained from Genex Cooperative Inc. (Shawano, WI). 
Spermatozoa from nine bulls  (-2.9 to 3.5 CR) was used to generate the amplified 
cDNA pool for RNA-Seq, for qPCR validation and PCR amplification of the 5’ and 3’ 
exons.  Spermatozoal RNA from nine additional bulls was also converted to cDNA 
and amplified for PCR amplification of transcripts in individual bulls.  Finally, a 
separate pool of spermatozoa RNA from three different bulls was not cDNA amplified 
and used for PCR amplification of full-length transcripts. Two straws per bull were 
thawed in a 37°C water bath for one minute and then washed twice in 4 mL PBS (10 
minutes at 600 x g). The resulting spermatozoa pellet was subsequently used for RNA 
isolation.   
 
RNA Isolation 
     Bull testis RNA was isolated with TRIZol (Sigma-Aldrich; St. Louis, MO).  
Spermatozoal RNA isolation was conducted using the TRIzol method reported by Das 
et al., 2010 [8] with slight modifications.  Spermatozoa pellets were added to 1 mL 
TRIzol supplemented with glycogen (15 µg/ml).  Samples were then lysed through a 
26 gauge needle 20 times and incubated for 30 minutes at room temperature.  
Chloroform was added to the samples followed by a 10 minute incubation at room 
temperature.  For phase separation, samples were centrifuged at 12000 x g for 15 
minutes at 4ºC.  The top layer (RNA) was removed and added to 500 µL ice cold 
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isopropanol and incubated on ice for 10 minutes followed by centrifugation 12000 x g 
for 10 minutes at 4ºC to precipitate the RNA. RNA pellets were washed with 1 mL 
75% ethanol and air dried, followed by resuspension in nuclease free water.  RNA 
samples were treated with DNAse using the RNA Cleanup protocol from the RNeasy 
Mini Kit (Qiagen, Valencia, CA).  RNA concentrations were measured using the 
NanoDrop UV/Vis Spectrometer (Thermo Scientific; Wilmington, DE) and RNA 
samples stored at -80º C until used for subsequent analysis. 
 
Double-Stranded cDNA (ds-cDNA) Synthesis and Amplification 
     Due to low RNA yields typical of spermatozoal RNA isolations, the spermatozoal 
RNA was converted to ds-cDNA and amplified for RNA-Seq analysis and qPCR 
validation (SMARTer Pico PCR cDNA Synthesis Kit; Clontech, Mountain View, 
CA). This method maintains gene representation in the original RNA pool.  Due to the 
varying amounts of RNA extracted from each bull, the amount of RNA added for 
amplification was normalized to the sample with the lowest concentration to ensure 
equal representation of the nine bulls in the pooled sample. The amplification protocol 
enriches the full-length mRNA population with a modified oligo(dT) primer. 
Amplification cycles were optimized to 26 cycles following the protocol instructions 
to insure amplification the linear phase. Following ds-cDNA conversion and 
amplification, 5 µg of spermatozoal ds-cDNA was submitted for Illumina sequencing 
and the remaining spermatozoal ds-cDNA was used for qPCR validation post-
sequencing.  To verify the quality of ds-cDNA, an aliquot of the sample was run on 
the Agilent Bioanalyzer 2100 (Agilent Technologies; Santa Clara, CA).   
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PCR 
     PCR reactions validated the lack of genomic DNA and somatic cell RNA in the 
spermatozoal RNA as well as full-length and 5’ and 3’ exon amplification in the 
spermatozoal transcript profile.  All PCR reactions were conducted with intron 
spanning primers (Table 1).   Most PCR reactions were run with spermatozoal ds-
cDNA except for the spermatozoal ds-cDNA sample that was spiked with genomic 
DNA (1 µg) isolated from the bull testis tissue (Lane G in Figure 1; Qiagen DNA 
Blood and Tissue kit; Valencia, CA).  For amplification of full-length transcripts from 
unamplified ds-cDNA, spermatozoal RNA (1 µg) was reverse transcribed using the 
Superscript III Reverse Transcriptase Kit (Invitrogen, Carlsbad, CA).  1 µL OligoDT 
primers (IDT, Coralville, IA), 1 µL dNTPs, 2 µg mRNA from the isolation and 1 µL 
water are combined, incubated at 65O C for 5 minutes, then chilled on ice for a minute. 
Following the chill,  4 µL 5X First Strand Buffer, 1 µL 0.1 mM DTT, 1 µL RNaseOut, 
and 1 µL Superscript III were added to the tube, incubated at 50O C for 45 minutes, 
then 70O C for 15 minutes. Then RNase H was added and the sample was incubated at 
37O C for 20 minutes. This procedure converts the mRNA to cDNA for use in PCR 
amplification.  For all primer pairs, cDNA was added to a PCR reaction mixture 
containing 1X reaction buffer, 1.5 mM MgCl2, 10 mM dNTPs, 2.5 µmol forward and 
reverse primers and 2.5 U Taq polymerase (NEB; Ipswich, MA) and run with standard 
PCR conditions (94°C for 5 min, 35 cycles of 94°C for 30 sec), primer dependent 
annealing temperature for 30 sec then 72°C for 2 min followed by a final extension at 
72°C for 10 min). Negative controls containing no template cDNA and no enzyme 
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were run in parallel to ensure gene specific amplification. The PCR products were 
separated by 2.0% agarose gel electrophoresis then gel purified (Qiagen Gel 
Extraction kit; Valencia, CA) and both strands sequenced (URI Genomics Center, 
Kingston, RI).  Amplicon sequence identity was confirmed with NCBI BLAST.  
 
RNA-Seq and Analysis 
     Paired-end 100 bp reads from spermatozoal ds-cDNA were generated using the 
Illumina HiSeq 2000 (Otogenetics; Norcross, GA).  Sequence analysis was conducted 
with Galaxy [28-30]. Reads were converted with FASTQ groomer and then aligned to 
the bovine genome (Btau6/UMD_3.1) using Tophat [31]. Trimming the adapter 
AGATCGGAAGAGC removed 14.29% (2,659,330 reads) from file 1 and 1.14% 
(211,176 reads) from file 2. Adaptor only reads, short sequence reads (15 nt 
minimum) and reads with unknown N bases were discarded during adapter trimming.  
Concatamers formed from amplification of the SMARTer II A Oligonucleotide 
(AAGCAGTGGTATCAACGCAGAGTAA) were found in 41.48% (7,702,931 reads) 
for file 1 and 47.17% (8,760,365 reads) for file 2 and were removed prior to further 
analysis. Alignment to the reference genome (UMD 3.1/bosTau6) was conducted 
using Tophat, which uses Bowtie for alignment [32].  A maximum of two mismatches 
were allowed during alignment.  RSeQC was used to generate read and post-alignment 
summary statistics [33].  Levels of individual transcripts are expressed in fragments 
per kilobase of exon per million fragments mapped (FPKM) and were obtained using 
Cufflinks [30].  Quantification of full-length transcripts was conducted by manually 
visualizing the read mapping for individual transcripts to the bovine genome (UMD 
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3.1/bosTau6) in the UCSC Genome Browser (http://genome.ucsc.edu/).  Reads were 
archived in the NCBI SRA055325 (http://www.ncbi.nlm.nih.gov/sra). 
 
qPCR 
     Quantitative PCR was used to validate RNA-Seq expression levels of the 
cryopreserved spermatozoal ds-cDNA.  Nine transcripts were chosen that represented 
a range of FPKM values (9.41 to 20,667). A standard curve was generated by diluting 
DNA for each transcript into 7 concentrations ranging from 1x109 copies to 1x103 
copies/ul.  qPCR was performed with spermatozoal ds-cDNA and standard curves 
using the Brilliant II SYBR Green QPCR Master Mix Kit (Stratagene; Santa Clara, 
CA).  All qPCR samples included negative template controls and were run in duplicate 
on the Stratagene Mx3005 instrument at the Genome Sequencing Center at the 
University of Rhode Island.  Amplicon sequence identity was confirmed with NCBI 
BLAST.  
 
Gene Ontology Analysis 
 Gene ontology analysis was conducted with the DAVID Bioinformatic 
Database (http://david.abcc.ncifcrf.gov/) using the three Gene Ontology Term 
categories: Biological Process, Molecular Function, and Cellular Component.  
Transcripts were analyzed in two different populations: FPKM>0 and FPKM>100.  
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Results 
Bovine spermatozoal RNA purity 
     Using the Trizol method, the total amount of RNA isolated from two spermatozoa 
straws from an individual bull resulted in an average of 31 fg RNA per spermatozoa. 
Bioanalyzer analysis of the spermatozoa RNA population shows a peak of smaller 
RNAs and a lack of 18S and 28S ribosomal RNA peaks present in testis RNA (Figure 
1A).  The spermatozoal RNA was free of leukocytes, testicular germ cells and 
epithelial cells as demonstrated by the lack of C-KIT, CD45, and CDH1 amplification 
respectively (Figure 1B).  Genomic DNA was also not detected in the isolated bovine 
spermatozoal RNA compared to a sample spiked with genomic DNA (Figure 1C).   
 
Illumina Sequencing  
     High-throughput sequencing of the bovine spermatozoal RNA resulted in 
18,570,350 x 2 paired-end 100-bp reads.  After removal of concatamers, a total of 
2,538,688 reads (14.25%) of the total population mapped to the bovine genome with 
79.84% of the aligned reads being uniquely mapped to a single transcript.  Reads 
aligned specifically to coding exons (324,600 reads), 5’UTRs (39,758 reads), 3’UTRs 
(40,057 reads), and 2,274 reads contained poly(A) sequences. Exon-exon junctions 
(157,717 reads over 17,285 junctions) were covered and 100,929 of those reads 
(64.21%) mapped to 9,003 annotated junctions while 56,248 (35.79%) reads mapped 
to 8,282 novel/partial junctions.  All junctions were supported by at least two reads.  
Also, 144,432 intronic reads were found, several of which may represent novel exons.  
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Cryopreserved Bovine Spermatozoal Transcript Profile  
 A total of 6,166 transcripts were identified in spermatozoal RNA with a FPKM>0 
(Fragments Per Kilobase of transcript per Million reads mapped). The qPCR 
expression values showed a high correlation with FPKM values (r2 =0.9747; Figure 2). 
The bovine spermatozoal transcript profile contains predominantly nuclear-encoded 
mRNAs including 33 mitochondrial-encoded rRNAs and mRNAs representing 0.5% 
of the spermatozoal transcript profile.  Many of these mitochondrial transcripts were 
highly abundant, with 32 of 33 in the top 100 transcripts ranked by FPKM.  The top 
10 transcripts based on FPKM, excluding the mitochondrial RNAs, are listed in Table 
2.  
A heterogeneous population of degraded and full-length transcripts was identified. 
Degraded transcripts (lacking reads mapping to all exons) were more prevalent below 
FPKM = 100.  Due to this observation, all transcripts with FPKM>100 (368 
transcripts) were analyzed individually for reads mapping to each exon to be 
considered a full-length transcript.    In the FPKM>100 population, 66% of the 
transcripts had reads aligned to all exons, including amplification of the 5’ and 3’ 
exons, potentially indicating the presence of full-length transcripts in the spermatozoal 
RNA population (Supplementary Table 1). Some of these full-length transcripts also 
included intronic reads that potentially represent novel exons.  Retention of the 5’and 
3’ exons for PLCZ1, CRISP2, and GSTM3 were validated while many transcripts with 
FPKM<100 did not retain the 5’ exon, including DDX3Y (Figure 3A).  The presence 
of full-length transcripts for GSTM3 and GSTF1 was confirmed by PCR amplification 
of the intact transcript from the first to last exon in unamplified cDNA (Figure 3B).  A 
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preliminary survey of the bovine spermatozoal transcript profile for previously 
reported spermatozoal RNA candidates identified several transcripts in bovine, human, 
porcine and mouse (Table 3).  These transcripts represented a wide range of FPKM  
levels, and nine of these transcripts retained the 5’ and 3’ exons, potentially indicating 
that these transcripts are also full-length (Table 3). 
A number of additional full-length bovine spermatozoal transcripts have not been 
previously reported in spermatozoal RNA, including HMGB4, PSMA6, GTSF1, and 
CKS2 (Table 4). Variation in the amount of select transcripts among bulls was 
demonstrated in an independent population of nine bulls (not included in RNA-Seq 
population; Figure 4). 
 
Gene Ontology Analysis 
     For gene ontology analysis, spermatozoal transcripts were analyzed in two different 
populations: FPKM>0 (n= 6,166) and FPKM>100 (n= 368). Transcripts were 
classified into the following  ontological categories: Biological Processes (BP), 
Cellular Components (CC), and Molecular Functions (MF) and the top ten categories 
for each are shown in Table 5.  In the total spermatozoal transcript population 
(FPKM>0), 367 BP, 142 CC, and 161 MF categories were found.  It is important to 
note that an individual transcript can be represented in multiple categories.  The top 
BP categories included translation (GO: 0006412; 264 transcripts) and proteolysis 
(GO: 0051603; 241 transcripts). Because a majority of full-length transcripts were 
found in the FPKM>100 population, we also analyzed this population separately.  
Translation remained the most predominant BP represented within this population (55 
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transcripts).  Within the translation category, 38 of the 55 transcripts encoded for 
ribosomal proteins and the remaining transcripts included eukaryotic translation 
initiation factors (EIF1 and EIF5), eukaryotic translation elongation factors (EEF1A1 
and EEF1γ), polyubiquitin and unknown transcripts. Twenty-four of these ribosomal 
transcripts were full-length (all exons mapped), as well as EEF1A1, EEF1γ and 
polyubiquitin.  
 
Discussion 
     Here, we report the first cryopreserved bovine spermatozoal transcript profile using 
RNA-Seq, which includes degraded and full-length nuclear-encoded transcripts and 
mitochondrial-encoded RNA.  The dynamic range of RNA-Seq allows for accurate 
identification and quantification of transcripts  present at very low and high levels as 
well as the discovery of more transcripts, novel splicing junctions and novel exons 
than reported in previous microarray studies [7, 9, 10]. In addition to the identification 
of transcripts not previously reported in spermatozoal RNA, several known 
spermatozoal transcripts from a number of different species were also found. Gene 
ontology analysis of the highly abundant spermatozoal transcripts (FPKM>100) 
revealed that translation was the most predominant biological process represented.  
The presence of full-length transcripts in transcriptionally-silent spermatozoa suggests 
that these transcripts could be translated after spermatogenesis is complete, potentially 
contributing to capacitation and early embryogenesis [1, 3].     
     Spermatozoal RNA isolation procedures have been developed to maximize yield 
and ensure elimination of somatic cell RNA.  The total amount of cryopreserved 
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bovine spermatozoal RNA isolated in this study (31 fg RNA per spermatozoa) was 
comparable to the RNA content previously reported in bovine (10-140 fg), human 
(12.5 fg), rat (100 fg), porcine (5 fg), and equine (20 fg) spermatozoa [reviewed in 1, 
8].   
     In this study, RNA was isolated from the whole cryopreserved semen straw, after a 
wash to remove the cryoprotectant, without the removal of non-motile spermatozoa. 
Using the entire spermatozoa population is representative of the natural transcript 
variation present across a range of fertility scores for bulls used in artificial 
insemination and is consistent with the approach used in other studies [12, 21, 24, 34].  
     The focus of this study was to enrich for and sequence the polyA+ transcripts 
present in transcriptionally-silent spermatozoa. The mitochondrial-encoded rRNAs 
and mRNAs sequenced in this population were some of the most abundant transcripts 
although these mitochondrial RNAs represented only 0.5% of the total transcripts. 
Mitochondrial rRNAs and mRNAs have been previously amplified in spermatozoa 
[10, 19] and the presence of these transcripts is likely due to intact mitochondria 
present during the RNA isolation procedure and the high mitochondrial activity of 
spermatozoa.  Poly(A-) transcripts and microRNAs were not evaluated in this study 
but probably present in the total bovine spermatozoa RNA population [4]. 
      Using RNA-Seq, we identified several full-length transcripts in the bovine 
cryopreserved spermatozoal transcript profile.  While some of these transcripts were 
previously reported in spermatozoa, the presence of full-length transcripts could not be 
determined from the microarray studies.   The most abundant full-length transcript, 
PRM1, has been reported in spermatozoa from other species as well, including humans 
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and porcine [7, 13, 20, 35].  The high level of PRM1 is probably due to retention of 
this transcript in elongating spermatids during the later stages of spermatogenesis.  A 
function for PRM1 after spermatozoa leave the testis is doubtful as Prm1 transcripts 
are rapidly degraded in the mouse embryo [15, 16].  Other transcripts are delivered to 
the oocyte after fertilization, including the Y chromosome-linked DBY and RPS4Y, 
were not identified as full-length transcripts in this study, therefore, a functional role 
in embryogenesis for these transcripts is also unlikely [17].  
     Polyubiquitin is also an abundant full-length transcript in bovine spermatozoa.  The 
ubiquitin system has several functions during spermiogenesis and fertilization, 
including: histone removal, removal of damaged epididymal spermatozoa, and aiding 
in zona penetration [36, 37].  Disruption of the ubiquitin-proteosome pathway during 
spermatogenesis is characteristic of teratozoospermic males and can be detected in 
human spermatozoal RNA [22]. Spermatozoa-derived ubiquitin RNAs may also have 
a role in directing the degradation of paternal mitochondrial RNAs, ensuring exclusive 
maternal mitochondrial DNA inheritance [36].  Further investigation of a role for 
spermatozoal-derived polyubiqutin mRNA pre- and post-fertilization is warranted. 
Previously reported spermatozoal transcripts involved in capacitation and 
fertilization were also identified as full-length, including: PLCZ1, CRISP2 and 
CLGN1.  PLCΖ1, a well-characterized activator of the calcium wave after fertilization, 
is translated in the oocyte and injections of PLCZ1 RNA into the oocyte are also 
sufficient for function [18].  PLCZ1 is present at lower amounts (FPKM= 41.3) in the 
bovine spermatozoa transcript profile demonstrating that functional transcripts may 
not be the most abundant transcripts in this population. The presence of full-length 
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CRISP2 could be indicative of potential translation at fertilization as CRISP2 is one of 
the spermatozoal proteins involved in oocyte binding [38].  The CLGN1 protein is 
necessary for heterodimerization of fertilization proteins [39, 40].  The presence of 
spermatozoal mRNA for critical fertilization proteins may be necessary to ensure 
appropriate function.   
     A number of previously unreported spermatozoal transcripts are full-length and 
abundant in the bovine spermatozoal transcript profile including HMGB4, PSMA6, 
GTSF1, and CKS2 although a role of transcripts from spermatozoal-derived mRNAs is 
speculative.  HMGB4 is found at the basal pole of elongating spermatids and is a 
transcriptional repressor [41].  PSMA6 is an alpha subunit of proteasomes; inhibition 
of spermatozoal proteosomes blocks fertilization by preventing spermatozoa 
penetration of the zona pellucida [42].  GTSF1 is critical for the suppression of 
retrotransposons in the male germ cells, as well as causing meiotic arrest in knockout 
mice [43].  CKS2 is critical in early embryonic development, where it controls cell 
proliferation [44]. In knockout studies of CKS2 and CKS1, embryos arrest 
development before the morula stage due to cyclin B1 downregulation [44].  
     A predominant function of the bovine spermatozoal transcripts with FPKM>100 is 
translation and includes abundant transcripts for ribosomal proteins, polyubiquitin 
(discussed above), eukaryotic translation initiation factors (EIF1 and EIF5), and 
eukaryotic translation elongation factors (EEF1A1 and EEF1γ). EIF1A1 is present in 
human spermatozoa [24] but EIF1, EEF1γ and EIF5 have not been previously 
reported in any species.  The translation elongation factors EEF1A1 and EEF1γ were 
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full-length in this study therefore a role for these transcripts in the early stage embryo 
is an interesting area for further investigation.      
     One-third of the transcripts with FPKM>100 were degraded (all exons were not 
mapped).  A predominance of degraded transcripts was also found in the FPKM<100 
transcript population although this was not quantified.  A degraded RNA population is 
characteristic of the spermatozoal RNA populations isolated in previous studies [7, 8] 
and large subset of the spermatozoal mRNAs are probably remnants from gene 
expression during spermatogenesis and do not have a function.  The relatively higher 
levels of most of the full-length transcripts is probably not due to a 3’ end bias, which 
can occur with RNA-Seq, due to the RNA amplification protocol that selectively 
amplified full-length transcripts [45]. Although full-length transcripts were identified, 
the proportion of degraded and full-length transcripts for an individual transcript could 
not be distinguished and the abundance values reported probably represent a sum of 
the full-length and fragmented exons for each transcript and the levels of intact 
transcripts is then probably lower than these reported values. The presence of 
degraded mRNAs and full-length mRNAs are not necessarily mutually exclusive 
events and functional transcripts could be present in a heterogeneous population.   
     While the goal of this present study was to identify a full-range of poly(A+) 
mRNAs present in bovine spermatozoa to identify candidates for further investigation, 
biological replicates were not conducted and individual bulls were pooled for RNA-
Seq and for some validation although individuals with a wide range of known fertility 
scores were used.  The pool of mRNA from our spermatozoa population contains 
several previously reported transcripts therefore the likelihood that the identified 
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transcripts are only present in this population of bulls is low but additional transcripts 
may be identified in other individuals.  
     The diagnostic potential of the total spermatozoal RNA population (degraded and 
full-length transcripts) is emerging.  Individual transcripts are stably regulated within 
and between individual males and perturbation of the ubiquitin-proteosome pathway 
during spermatogenesis could be detected in the spermatozoal RNA [22, 23]. The 
amount of specific transcripts, including PRM1, PRM2, CRISP2, CCT8, PEBP1 and 
CD36, have also been correlated to fertility in humans and bulls [10-12, 20, 46]. These 
transcripts are full-length in this bovine spermatozoal transcript profile, so prediction 
of fertility for some of these transcripts may be due to a functional role (for example 
CRISP2) and not just a representation of transcription during spermatogenesis (for 
example, PRM1 and PRM2).  If the degraded mRNA population is stably regulated, 
this population can also be used to as a diagnostic tool. Spermatozoal transcript 
populations also vary with motility, morphology, DNA integrity and seasons [47-51]. 
The spermatozoal transcript profile reported here was sequenced from a pool of bulls 
that represent a normal range of fertility scores. While the presence of specific 
transcripts did vary in an independent population of bulls, further quantitative analysis 
in a much larger population will better assess the level of individual bull variation and 
a correlation of transcript levels with fertility scores.  
     This is the first report of the spermatozoal transcript profile in any species using 
high-throughput sequencing, supporting the presence of mRNA in spermatozoa.  
Further studies of the spermatozoal mRNA candidates identified will contribute to our 
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knowledge of the function of spermatozoal mRNA and expand our approaches to 
assay male fertility. 
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Figures 
Figure 1. Purity of bovine cryopreserved spermatozoal RNA was confirmed by lack of 
somatic cell RNAs and genomic amplification. (A) Bioanalyzer analysis of testis RNA 
and spermatozoal RNA prior to amplification.  (B) Cell-specific transcripts for 
testicular germ cells (C-KIT), leukocytes (CD45) and epithelial cells (CDH1) did not 
amplify in the spermatozoal RNA (Lane S).  M= 100 bp DNA marker, T = testis RNA 
positive control and N = negative control that does not include cDNA template. (C) 
The spermatozoal RNA (Lane S) does not contain genomic DNA compared to 
amplification of genomic EIF1 in spermatozoal cDNA spiked with genomic DNA 
(Lane G). N = negative control that does include cDNA template.  
 
54 
 
Figure 2. Correlation of qPCR transcript copy number and RNA-Seq FPKM 
based on nine transcripts. Axes are base 10 log scale. 
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Figure 3. PCR amplification of (A) the 5’ and 3’ ends of DDX3Y, PLCZ1, CRISP2 and 
GSTM3 in amplified ds-cDNA. For 5’ end primers, all primers begin in the first exon, 
and for 3’ end primers, all primers end in the last exon.  All primer sets are intron-
spanning. N = negative control that did not include cDNA template and M = 100 bp 
DNA marker.  (B) Transcripts for GSTM3 and GTSF1 were PCR amplified using 
primers within the first and last exons in order to capture full-length transcripts. The 
cDNA for this section was used from the 3-bull pool created from a Superscript III 
Reverse Transcription of mRNA (Invitrogen, Carlsbad, CA) 
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Figure 4. PCR amplification of select transcripts in individual bull spermatozoa 
amplified cDNA 
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Tables 
Table 1. Bovine primer sequences. *Genomic DNA amplicon which includes 144 bp 
intron 
   Primer Sequences  
Gene 
Symbol 
Genbank 
ID   Forward Reverse 
Product 
Size (bp) 
BTF3A AB098942 qPCR 5'- GGTGGTTCATAGAACAGCAACAGC 
-3' 
5'- GGCACCAAGCTGGTTTAAGATGCT 
-3' 244 
CD45 AJ400864 
 PCR 
5'- TGGACGAAATTGCATCCCTCAGGA 
-3' 
5'- TGGTCAGGACGTTTACAGCTCACA 
-3' 237 
CDH1 AY508164 
 PCR 
5'- ACCATGGACTTCTGCCAGAGGAAT 
-3' 
5'- TGGTCACCTGGTCTTTGTTCTGGT -
3' 244 
CHMP5 BC103182 qPCR 5'- TGGCACGGTGGACAGCAGAG - 3' 5' - TGGGCGAGATTGTCCCGCTG - 3'  189 
C-KIT AF263827 
 PCR 
5'- TATAGCACCATTGATGACAGCACA 
- 3' 
5'- TTATCTCCTCGACAACTTTCCACT -
3' 268 
CKS2 BC105331 Individual Variation 5' - GAGTCGAGTCGTTGCCTTCA -3' 5'-GGACACCAAGTCTCCTCCAC -3' 248 
CRISP2 BC109478 5' Set 5'-CGGCCGCTCTGCAACAGAAG-3' 5'-GGAAGCAGCACAGCGGTCAGA-3' 120 
  
3' Set 5'-CACCTTGCGGCAGTTGCCCT-3' 5'-TGCCTTCACACAGACAAGTCGCC-3' 165 
DDX3Y GQ259590 5' Set 5'- TTGTTTCCGGTAGACCAACCTGTG- 3' 5'- AGCGCCCTTTGCTAGCTGTACT -3' 220 
  
3' Set 5'- GGCCGTTCTAGGAGATTCAGTGG -3' 
5'- 
CAACTGAATCTGCTTTCCAGCCAAG -
3' 
246 
EIF1 BC103170 qPCR 5'- AAGGGTGATGATCTGCTTCCTGCT -3' 
5'- AACTGGCATATGTTCTTGCGCTGG -
3' 235 (379)* 
EIF4A BC103130 qPCR 5'- TGCCTTCTGATGTGCTTGAGGTGA -3' 
5'- TGAAGTCTCGGGCATGCATCTTCT -
3' 246 
GSTM3 BC112491 5' Set 5'-GCGCTAAGGCACACAGGCGA-3' 5'-TGCGGGCGATGTAGCGCAAG-3' 290 
  
3' Set 5'-TGTGCCGTTTTGAGGCTTTGGAG-3' 5'-GGGCCATCTTGTTGTTGACAGGCAT-3' 90 
  
5' to 3' Exon 5'-GCGCTAAGGCACACAGGCGA-3' 5'-GGGCCATCTTGTTGTTGACAGGCAT-3' 679 
GTSF1 BC102713 5' to 3' Exon 5'-ACAAACTGGCAACTTGTCCCT-3' 5'-GAACACACTGTAGCGGGAAGA-3' 427 
HMGB4 BC109790 qPCR 5'- AGCTGGTCGGTGGTGCAGGT -3' 5'- GCAAGCATGTCTTCCGGGC -3' 167 
PLCZ1 BC114836 5' Set 5'- GGTGCCCGGCCAACCAGTTAT -3' 5'- TGCCGCTTGGCAAGAAAGGG -3' 138 
  
3' Set 5'- GTGGTATCCAGTTGCCTCCCAGT -3' 5'- GCGGGCTCAAGACTCTCACCC -3' 319 
  
qPCR 5'- CGGGTGGTCGGAATCCCACTCT -3' 5'- AATTCCCTGGCTGCCAACTTTGT -3' 194 
PRM1 BC108207 qPCR 
5'- 
AAGAAGATGTCGCAGACGAAGGAG -
3' 
5'- ACAGGTGGCATTGTTCGTTAGCAG 
-3' 228 
PSMA6 BC110260 qPCR 
5'- 
ACAGTGGAAACTGCGATTACATGCC - 
3' 
5' - ACAGGCAAGTGGCGTCACGG - 3' 205 
SEC61G BC102186 qPCR 5'- GCAGACGCGGAGCAGACATCA -3' 5'- AGCGAATCCTATTGCTGTTGCCA -3' 155 
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Table 2. Top 10 bovine spermatozoal transcripts based on FPKM. 
Million fragments mapped (FPKM) 
Gene Symbol Gene Name Accession Number FPKM 
PRM1 Protamine 1 BC108207; M14559 20667; 12461 
LOC783058 Hypothetical Protein BC126791 10290 
HMGB4 High mobility group box 4 BC109790 6022 
LOC404073 Histone 2B variant PT15 BC108210; AF315690 3048; 2158 
CHMP5 Chromatin modifying protein 5 BC103182 2778 
TMSB4X Thymosin beta 4 X-linked FJ795030 2487 
LOC281370 Polyubiquitin AB099044 2426 
GSTM3 Glutathione S-transferase mu 3 BC112491 2374 
N/A cDNA clone IMAGE:7944277 BC134702 2050 
KIF5C Kinesin family member 5C BC151732 1862 
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Table 3. Comparing 5’ and 3’ exons in transcripts from previous literature 
 
End Exons 
Intact 
Transcript 
Accession 
# FPKM 5' 3' Reference Species 
Accession 
# 
PRM1 BC108207 20667.2 Y Y 
Ziyyat, 1999; Gilbert, 2007; 
Kempisty, 2008; Hecht, 2010; 
Feugang, 2010 
H; B; 
P; B, 
Ma; B BC108207 
CHMP5 BC103182 2778.08 N N Zhao et al., 2006; Lalancette, 2008 H BC103182 
TNP1 X16171 1287.96 Y Y Iguchi, 2006 M X16171 
TNP2 BC109800 1206.79 N Y Miller, 2005 M BC109800 
SMCP BC109542 938.502 Y Y Iguchi, 2006; Yang 2009 M BC109542 
CLGN BC103401 220.011 Y Y 
Kempisty, 2008; Ostermeier, 2004; 
Wang, 2004 P BC103401 
TMBIM6 BC102469 196.512 N Y Gilbert, 2007 B BC102469 
PGK2 BC110004 173.412 Y Y Iguchi, 2006 M BC110004 
H2AFZ BC109743 166.742 N Y Gilbert, 2007 B BC109743 
LOC789867 
(EF-1, 
EEF1A1) AF013213 
133.722 Y Y 
Lalancette, 2008; Zhao, 2006 B AF013213 
AKAP4 AF100170 126.623 Y Y Gilbert, 2007; Ostermeier, 2004 B AF100170 
RPS4Y BC133507 53.0481 N Y Yao, 2009 M BC133507 
PRM2 BC109783 45.5481 N Y Hecht, 2010 B, Ma BC109783 
CLU BC118223 44.045 N Y Gilbert, 2007; Kempisty, 2008 B; P BC118223 
ACTG1 BC102951 43.7095 N Y Gilbert, 2007 B BC102951 
PLCZ1 AY646356 41.3639 Y Y Hamatani, 2012 H AY646356 
MYCBP BC109848 39.731 Y Y 
Lambard et al., 2004; Kumar et al. 
1993 H BC109848 
PEBP1 BC102389 29.3446 N Y 
Bissonette, 2009; Arangasamy, 
2011 B BC102389 
SPAG4 BC109514 25.6132 N Y Gilbert, 2007 B BC109514 
CCT8 AF136609 17.9915 N N Arangasamy, 2011 B AF136609 
DDX3Y FJ659845 10.9846 N N Sekiguchi, 2004; Yao, 2009 H; M FJ659845 
PPIH BC120220 10.946 N N Gilbert, 2007 B BC120220 
STRBP BC123453 7.26818 N N Gilbert, 2007 B BC123453 
FLOT1 BC104516 5.44937 N N Gilbert, 2007 B BC104516 
CSN2 S67277 4.76535 N Y Feugang, 2010 B S67277 
CRISP2 BC109478 4.07274 Y Y Arangasamy, 2011; Zhao, 2006 B BC109478 
EIF2B2 BC123823 2.93951 N N Gilbert, 2007 B BC123823 
SPATA20 BC123689 2.16637 N N Gilbert, 2007 B BC123689 
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Table 4. Top 10 previously unreported full-length bovine spermatozoal transcripts 
based on FPKM.  
Gene Symbol Gene Name Accession Number FPKM 
HMGB4 High mobility group box 4 BC109790 6022 
TMSB4X Thymosin beta 4 X-linked FJ795030 2487 
PSMA6 Proteosome subunit, alpha type, 6 BC110260 913 
GTSF1 Gametocyte specific factor 1 BC102713 896 
ZNF474 Zinc finger protein 474 BC108236 817 
COX7C Cytochrome oxidase subunit 7c X15725 733 
COX7A2 Cytochrome oxidase subunit 7a polypeptide 2 DQ347636 719 
MLF1 Myeloid leukemia factor 1 BC109859 517 
PFDN5 Prefoldin subunit 5 BC102252 405 
GABARAP GABA(A) receptor-associated protein AJ297742 385 
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Table 5. Top 10 gene ontology categories for all spermatozoal transcripts FPKM>0 
and for transcripts with FPKM>100. CP = Catabolic Process, Bi = Binding, Org = 
Organelle, NMBO = Non-Membrane Bounded Organelle, TTA = transmembrane 
transporter activity. 
All Transcripts Transcripts with FPKM > 100 
(% of Transcripts Per Category) (% of Transcripts Per Category) 
Bi
o
lo
gi
ca
l P
ro
ce
ss
 
Translation 4.91 Translation 14.55 
Proteolysis Involved In Cellular Protein CP 4.48 Protein Localization 6.18 
Cellular Protein CP 4.39 Precursor Metabolites And Energy 5.82 
Modification-Dependent Protein CP 4.02 Sexual Reproduction 5.45 
Modification-Dependent Macromolecule CP 4.02 Spermatogenesis 5.09 
Cellular Macromolecule CP 4.00 Male Gamete Generation 5.09 
Protein CP 3.57 Gamete Generation 5.09 
RNA Processing 3.52 Multicellular Organism Reproduction 5.09 
Macromolecule CP 3.40 Reproductive Process 5.09 
mRNA Processing 3.14 Protein Transport 5.09 
C
el
lu
la
r 
Co
m
po
n
en
t 
Intracellular NMBO 11.35 NMBO 25.82 
NMBO 11.35 Intracellular NMBO 25.82 
Mitochondrion 7.98 Ribonucleoprotein Complex 16.73 
Membrane-Enclosed Lumen 6.90 Ribosome 14.18 
Intracellular Org Lumen 6.64 Mitochondrion 12.36 
Org Lumen 6.64 Org Membrane 10.18 
Org Membrane 5.49 Org Envelope 8.73 
Cytoskeleton 5.15 Envelope 8.73 
Nuclear Lumen 4.91 Mitochondrial Part 8.36 
Ribonucleoprotein Complex 4.56 Mitochondrial Membrane 8.00 
M
o
le
cu
la
r 
Fu
n
ct
io
n
 
Ion Bi 15.68 Structural Molecule Activity 13.82 
Cation Bi 15.51 Structural Constituent Of Ribosome 13.09 
Metal Ion Bi 15.42 RNA Bi 4.73 
Nucleotide Bi 11.90 Hydrogen Ion TTA 4.36 
Transition Metal Ion Bi 10.86 Monovalent Inorganic Cation TTA 4.36 
Purine Nucleotide Bi 9.51 Inorganic Cation TTA 4.36 
Purine Ribonucleotide Bi 9.15 ATPase Activity 3.27 
Ribonucleotide Bi 9.15 Enzyme Bi 2.55 
Nucleoside Bi 7.44 Protein Domain Specific Bi 2.18 
Purine Nucleoside Bi 7.38 Heme-Copper Terminal Oxidase Activity 1.82 
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Table 6. Full-Length Trasncripts for the population of FPKM >100. 
Genbank 
ID 
Official Gene 
Symbol Full Name FPKM 
Full Length 
Transcript 
5' Exon 
intact 
3' Exon 
intact 
    Percent Yes:   65.76 70.65 88.59 
AB098851 ORCS10804 Bos Taurus Mitochondrial Rna, Similar To 16S Rrna 383371 Y Y Y 
AB098854 ORCS10931 Bos Taurus Mitochondrial Rna, Similar To 16S Rrna 301214 Y Y Y 
AB098841 ORCS10096 Bos Taurus Mitochondrial Rna, Similar To 16S Rrna 216612 Y Y Y 
AB098863 ORCS11599 Bos Taurus Mitochondrial Rna, Similar To 16S Rrna 149030 Y Y Y 
AB098844 ORCS10257 Bos Taurus Mitochondrial Rna, Similar To 12S Rrna 145266 Y Y Y 
AB099138 ORCS12829 Bos Taurus Mitochondrial Rna, Similar To 16S Rrna 133966 Y Y Y 
AB098853 ORCS10848 Bos Taurus Mitochondrial Rna, Similar To 12S Rrna 82000.2 Y Y Y 
BC108207 PRM1 Bos Taurus Protamine 1 20667.2 Y Y Y 
DQ347622 H97 Bos taurus clone H97 COX1 
mRNA 15042.7 Y Y Y 
M14559 PRM1 Protamine 1 12460.6 Y Y Y 
DQ347619 H31 Bos taurus clone H31 ND4 
mRNA 11070.1 Y Y Y 
DQ347618 ATP6 Bos Taurus Clone A14 Atp6 Mrna 10379.2 Y Y Y 
BC126791 LOC783058 Bos taurus hypothetical protein LOC783058 10289.7 Y Y Y 
AB098808 ORCS12903 
Bos taurus mitochondrial 
mRNA for similar to 
ATPase 6 
10255 Y Y Y 
DQ347621 H63 Bos taurus clone H63 COX2 
mRNA 9735.03 Y Y Y 
AB099097 ORCS11619 Bos Taurus Mitochondrial Rna, Similar To D-Loop 8300.97 Y Y Y 
AB098776 ORCS12073 
Bos Taurus Mitochondrial 
Mrna For Similar To 
Cytochrome Oxidase III 
7772.1 Y Y Y 
AB098777 ORCS12084 
Bos Taurus Mitochondrial 
Mrna For Similar To 
Cytochrome Oxidase III 
6720.22 Y Y Y 
BC109790 Hmgb4 High-Mobility Group Box 4 6021.96 Y Y Y 
AB099131 ORCS11856 Bos taurus mitochondrial RNA, similar to 12S rRNA 5795.61 Y Y Y 
DQ347627 H40 Bos taurus clone H40 COX2 
mRNA 5408.65 Y Y Y 
AB099077 ORCS13694 
Bos taurus mitochondrial 
mRNA for similar to 
cytochrome oxidase I 
5297.64 Y Y Y 
AB098902 ORCS10210 
Bos taurus mRNA for 
similar to cytochrome 
oxidase I 
5046 Y Y Y 
AB099009 ORCS12081 Bos taurus mRNA for 
similar to cytochrome b 4319.09 Y Y Y 
AB098967 ORCS11394 Bos Taurus Mrna For Similar To Cytochrome B 3394.89 Y Y Y 
BC126791 MGC148328 Bos taurus hypothetical protein LOC783058, mRNA 3198.14 Y Y Y 
FJ976184 ND5 
Bos taurus NADH 
dehydrogenase subunit 5 
(ND5) mRNA 
3091.53 Y Y Y 
BC108210 LOC404073 Histone H2B Variant Pt15 3047.5 Y Y Y 
AB098941 ORCS10715 Bos taurus mRNA for 
similar to cytochrome b 2918.85 Y Y Y 
BC103182 Chmp5 Chromatin Modifying Protein 5 2778.08 N N N 
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AB098789 ORCS12473 
Bos Taurus Mitochondrial 
Mrna For Similar To 
Cytochrome Oxidase III 
2521.74 Y Y Y 
FJ795030 LOC785455 Thymosin Beta 4, X-Linked 2486.99 Y Y Y 
AB099044 LOC281370 Polyubiquitin 2425.89 Y Y Y 
BC112491 GSTM3 Glutathione S-Transferase Mu 3 (Brain) 2373.84 Y Y Y 
AF315690 LOC404073 Histone H2B Variant Pt15 2158.22 Y Y Y 
AB098774 ORCS11961 
Bos taurus mitochondrial 
mRNA for similar to 
cytochrome oxidase III 
2133.68 Y Y Y 
AB099096 ORCS11109 Bos taurus mitochondrial RNA, similar to D-loop 2091.43 Y Y Y 
BC134702 IMAGE:7944277 Bos taurus cDNA clone IMAGE:7944277 2050.08 Y Y Y 
AB098801 ORCS12731 
Bos taurus mitochondrial 
mRNA for similar to 
cytochrome oxidase III 
2029.43 Y Y Y 
BC151732 KIF5C Kinesin Family Member 5C 1862.47 Y Y Y 
BC123382 LOC777592 Hypothetical Protein Loc777592 1846.72 N N Y 
BC126793 IMAGE:8056303 Bos taurus cDNA clone IMAGE:8056303 1808.5 N N Y 
AB098980 ORCS11606 
Bos taurus mitochondrial 
mRNA for similar to NADH 
dehydrogenase subunit 1 
1586.19 Y Y Y 
AB098969 ORCS11414 
Bos taurus mRNA for 
similar to NADH 
dehydrogenase subunit 1 
1563.82 Y Y Y 
BC114001 LOC281370 Polyubiquitin 1520.12 Y Y Y 
BC111648 MGC137055 Hypothetical Protein Mgc137055 1466.25 Y Y Y 
AB098767 ORCS11606  Bos taurus mitochondrial 
mRNA, similar to protein 1 1310.8 Y Y Y 
X16171 tnp1 Transition Protein 1 1287.96 Y Y Y 
BC109730 C13H20orf79 Chromosome 20 Open Reading Frame 79 Ortholog 1237.94 Y Y Y 
BC142065 IMAGE:8037824 Bos taurus cDNA clone IMAGE:8037824 1224.68 Y Y Y 
BC109800 LOC781496 
Similar To Tnp2 Protein; 
Transition Protein 2 (During 
Histone To Protamine 
Replacement) 
1206.79 N N Y 
BC126791 IMAGE:30957795 Bos taurus hypothetical protein LOC783058, mRNA 1137.99 Y Y Y 
AB098750 LOC614114 Cytochrome C Oxidase Subunit Vib Pseudogene 1099.5 N N Y 
BC111151 IMAGE:8052434 Bos taurus cDNA clone IMAGE:8052434 993.402 N N Y 
K00243 tRNA-Leu Bovine Mitochondrial Leu-Trna-Tag 972.836 Y Y Y 
AY796023 Smcp 
Sperm Mitochondria-
Associated Cysteine-Rich 
Protein 
938.502 Y Y Y 
BC109478 IMAGE:8048928 Bos taurus cysteine-rich 
secretory protein 2, mRNA 933.969 Y Y Y 
BC103421 Spa17 Sperm Autoantigenic Protein 17 927.374 Y Y Y 
BC110260 Psma6 
Proteasome (Prosome, 
Macropain) Subunit, Alpha 
Type, 6 
913.21 Y Y Y 
BC102663 C12orf54 Chromosome 12 Open Reading Frame 54 Ortholog 897.064 Y Y Y 
BC102713 GTSF1 Gametocyte Specific Factor 1 896.368 Y Y Y 
BC102609 C3H1orf182 
Chromosome 1 Open 
Reading Frame 182 
Ortholog 
887.309 Y Y Y 
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BC102599 GTSF1L Gametocyte Specific Factor 1-Like 861.791 Y Y Y 
BC108236 ZNF474 Zinc Finger Protein 474 816.725 Y Y Y 
BC102973 LOC539855 Histone H3-Like 805.895 Y Y Y 
AB099083 LOC281370 
Ubiquitin C; Polyubiquitin; 
Ubiquitin A-52 Residue 
Ribosomal Protein Fusion 
Product 1 
797.874 Y Y Y 
DQ347600 A24 
Bos Taurus Clone H1 
Atpase Na+/K+ 
Transporting Beta 3 
Polypeptide-Like Mrna 
786.943 Y Y Y 
BC126792 LOC784495 Hypothetical Protein Loc784495 741.663 Y Y Y 
X15725 Cox7c Cytochrome C Oxidase Subunit Viic 732.771 Y Y Y 
DQ347636 COX7A2 
Cytochrome C Oxidase 
Subunit Viia Polypeptide 2 
(Liver) 
719.358 Y Y Y 
BC109926 IQCF5 Iq Motif Containing F5 707.481 Y Y Y 
AB098957 LOC281370 Polyubiquitin 677.922 Y Y Y 
BC102598 tnp1 
Transition Protein 1 (During 
Histone To Protamine 
Replacement) 
676.993 Y Y Y 
BC103105 CISD1 Cdgsh Iron Sulfur Domain 1 656.043 N N Y 
BC114790 IMAGE:8063641 Bos taurus cDNA clone IMAGE:8063641 619.729 N N Y 
BC109542 Smcp 
Sperm Mitochondria-
Associated Cysteine-Rich 
Protein 
604.724 Y Y Y 
BC148014 rpl23 Ribosomal Protein L23 599.605 Y Y Y 
BC102582 MP68 6.8 Kda Mitochondrial Proteolipid 584.314 N N Y 
Z86042 LEO1 
Leo1, Paf1/Rna Polymerase 
Ii Complex Component, 
Homolog (S. Cerevisiae) 
562.891 Y Y Y 
BC110036 Clph Chromosome 4 Open Reading Frame 35 Ortholog 545.537 Y Y Y 
DQ347576 SLC25A5 
Solute Carrier Family 25 
(Mitochondrial Carrier; 
Adenine Nucleotide 
Translocator), Member 5 
542.739 Y Y Y 
M62428 LOC281370 
Ubiquitin C; Polyubiquitin; 
Ubiquitin A-52 Residue 
Ribosomal Protein Fusion 
Product 1 
538.61 N N Y 
K00194 tRNA-Glu Bovine Mitochondrial Glu-Trna-Uuc 533.929 Y Y Y 
BC111614 LOC768323 Hypothetical Protein Loc768323 522.375 Y Y Y 
BC109859 MLF1 Myeloid Leukemia Factor 1 516.634 Y Y Y 
AY911357 rpl31 
Similar To Ribosomal 
Protein L31; Ribosomal 
Protein L31 
507.005 Y Y Y 
AY260742 LIS1 
Bos taurus platelet 
activating factor 
acetylhydrolase 45 kDa 
subunit brain isoform (LIS1) 
mRNA 
503.684 Y Y Y 
J03604 GLUL Glutamate-Ammonia Ligase (Glutamine Synthetase) 500.939 Y Y Y 
BC102702 LOC782520 Ribosomal Protein S29 497.777 Y Y Y 
DQ347636 COX7A2 
Cytochrome C Oxidase 
Subunit Viia Polypeptide 2 
(Liver) 
496.514 Y Y Y 
BC109927 MORN2 Morn Repeat Containing 2 472.825 Y Y Y 
BC105360 spata6 Spermatogenesis Associated 6 453.406 Y Y Y 
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AF294616 TMSB10 Thymosin Beta 10 451.9 N N Y 
BC102650 MGC128040 Hypothetical Protein Mgc128040 442.179 Y Y Y 
BC149673 MGC152346 Uncharacterized Protein Loc285141 Homolog 440.761 Y Y Y 
BC126781 TXNDC8 Thioredoxin Domain Containing 8 (Spermatozoa) 433.154 Y Y Y 
S79980  RPL37 ribosomal protein L37 432.006 Y Y Y 
AB099079 LOC789867 Eukaryotic Translation Elongation Factor 1 Alpha 1 431.873 Y Y Y 
BC102748 rpl32 Ribosomal Protein L32 419.736 Y Y Y 
BC111614 LOC768323 Hypothetical Protein Loc768323 414.631 Y Y Y 
BC102252 PFDN5 Prefoldin Subunit 5 404.632 Y Y Y 
BC102044 RPL37A Ribosomal Protein L37A 403.288 N Y N 
BC109951 CAPZA3 
Capping Protein (Actin 
Filament) Muscle Z-Line, 
Alpha 3 
402.076 Y Y Y 
BC102248 LOC281370 Polyubiquitin 401.415 Y Y Y 
BC120080 CALM Calmodulin-Like 395.156 Y Y Y 
BC142077 IMAGE:8050622 Bos taurus cDNA clone IMAGE:8050622 393.899 N N Y 
AY186585 GLUL Glutamate-Ammonia Ligase (Glutamine Synthetase) 392.537 Y Y Y 
DQ347578 A17 Bos taurus clone A17 actin 
cytoplasmic 2 mRNA 387.604 Y Y Y 
AJ297742 GABARAP Gaba(A) Receptor-Associated Protein 384.967 Y Y Y 
BC142060 DNAJB7 Dnaj (Hsp40) Homolog, Subfamily B, Member 7 366.633 Y Y Y 
BC108144 BANF2 Barrier To Autointegration Factor 2 359.621 Y Y Y 
BC114198 IMAGE:8055902 Bos taurus cDNA clone IMAGE:8055902 357.25 Y Y Y 
BC105331 CKS2 Cdc28 Protein Kinase Regulatory Subunit 2 351.893 Y Y Y 
BC114201 IMAGE:8056539 Bos taurus cDNA clone IMAGE:8056539 348.138 Y Y Y 
BC149889 DCUN1D1 
Dcn1, Defective In Cullin 
Neddylation 1, Domain 
Containing 1 (S. Cerevisiae) 
342.726 Y Y Y 
AF109198 CLIC4 Chloride Intracellular Channel 4 338.487 Y Y Y 
BC126766 FAM24A Similar To Protein Fam24A 335.134 Y Y Y 
BC110256 Fam71d 
Family With Sequence 
Similarity 71, Member D 
Ortholog 
335.075 Y Y Y 
BC109624 cetn1 Centrin, Ef-Hand Protein, 1 332.853 N N Y 
BC102682 SERF2 Small Edrk-Rich Factor 2 330.258 N N Y 
BC102249 rps11 Ribosomal Protein S11 327.944 Y Y Y 
BC148018 rps17 Ribosomal Protein S17 327.412 Y Y Y 
BC109989 C13H20ORF71 Chromosome 20 Open Reading Frame 71 Ortholog 326.017 Y Y Y 
BC102437 atox1 Atx1 Antioxidant Protein 1 Homolog (Yeast) 320.276 Y Y Y 
DQ347614 LOC784052 40S Ribosomal Protein S26-2-Like 319.419 Y Y Y 
BC109725 SAA4 Serum Amyloid A4, Constitutive 319.23 Y Y Y 
U19802 btg1 B-Cell Translocation Gene 1, Anti-Proliferative 316.825 N N Y 
BC108179 RPL38 Ribosomal Protein L38 316.575 Y Y Y 
BC111617 Tmco2 Transmembrane And Coiled-Coil Domains 2 313.784 N N Y 
BC114194 IMAGE:8063913 Bos taurus cDNA clone IMAGE:8063913 311.9 Y Y Y 
BC103057 UQCRB Ubiquinol-Cytochrome C 309.82 Y Y Y 
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Reductase Binding Protein 
BC102186 sec61g Sec61 Gamma Subunit 309.446 Y Y Y 
AB098960 ORCS11043 
Bos taurus mRNA for 
similar to poly(A)-binding 
protein 1 
307.612 Y Y Y 
EU036210 BBD120 Bos taurus beta-defensin 120 mRNA 306.483 N Y N 
BC108218 C29H11orf10 Chromosome 11 Open Reading Frame 10 Ortholog 297.346 N N N 
BC103170 LOC781102 Eukaryotic Translation Initiation Factor 1 292.75 N N Y 
BC142260 taf10 
Taf10 Rna Polymerase Ii, 
Tata Box Binding Protein 
(Tbp)-Associated Factor, 
30Kda 
289.583 N N Y 
BC102743 Tmco5a Transmembrane And Coiled-Coil Domains 5A 287.894 N N Y 
BC108230 SERF1A Small Edrk-Rich Factor 1B (Centromeric) 277.569 N N Y 
AF058700 LOC281370 
Ubiquitin C; Polyubiquitin; 
Ubiquitin A-52 Residue 
Ribosomal Protein Fusion 
Product 1 
277.039 Y Y Y 
BC109684 LOC540268 Hypothetical Loc540268 272.881 Y Y Y 
BC102675 DCUN1D1 
Dcn1, Defective In Cullin 
Neddylation 1, Domain 
Containing 1 (S. Cerevisiae) 
269.749 Y Y Y 
M19217 Atp5j 
Atp Synthase, H+ 
Transporting, Mitochondrial 
F0 Complex, Subunit F6 
269.601 Y Y Y 
AY911383 LOC786337 Ribosomal Protein S24 267.359 N N Y 
BC102168 LOC781607 Ribosomal Protein L36A 262.035 N N Y 
BC103196 IMAGE:7986614 
Bos taurus transcription 
elongation factor B (SIII), 
polypeptide 2 
261.222 N N Y 
BC110154 MS4A13 
Membrane-Spanning 4-
Domains, Subfamily A, 
Member 13 
258.624 Y Y Y 
BC151426 LOC786258 Ran, Member Ras Oncogene Family 258.31 Y Y Y 
X15112 LOC614114 Cytochrome C Oxidase Subunit Vib Pseudogene 257.306 N N N 
BC109719 SPINK2 
Serine Peptidase Inhibitor, 
Kazal Type 2 (Acrosin-
Trypsin Inhibitor) 
248.263 Y Y Y 
BT030506 UBE2N 
Ubiquitin-Conjugating 
Enzyme E2N (Ubc13 
Homolog, Yeast) 
245.596 Y Y Y 
EU036209 BBD119 Bos taurus beta-defensin 119 mRNA 244.782 Y Y Y 
Z46789 CYLC2 Cylicin, Basic Protein Of Sperm Head Cytoskeleton 2 243.523 Y Y Y 
DQ347568 LOC781571 
Histidine Triad Nucleotide 
Binding Protein 1; Similar 
To Histidine Triad 
Nucleotide-Binding Protein 
1 
242.297 Y Y Y 
BC102631 LOC617040 Similar To Hcg23722 241.208 N Y N 
AY911363 LOC507141 Ce5 Protein-Like 241.165 Y Y Y 
BC108150 Selk Selenoprotein K 238.417 Y Y Y 
BC102957 GPX4 
Glutathione Peroxidase 4 
(Phospholipid 
Hydroperoxidase) 
238.117 N N Y 
BC149307 LOC100125949 Similar To Iq Domain-Containing Protein F1 235.802 Y Y Y 
AB099097 ORCS11619 Bos Taurus Mitochondrial Rna, Similar To D-Loop 235.006 Y Y Y 
BC110123 C16H1orf49 Chromosome 1 Open 234.333 Y Y Y 
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Reading Frame 49 Ortholog 
BC105361 Ldhc Lactate Dehydrogenase C 230.203 Y Y Y 
BC123583 AP2B1 Adaptor-Related Protein Complex 2, Beta 1 Subunit 228.35 N Y Y 
AY911358 LOC781565 Ribosomal Protein S6 227.299 Y Y Y 
DQ347613 rps8 Ribosomal Protein S8 222.367 Y Y Y 
AB098827 LOC781379 Dynein, Light Chain, Lc8-Type 1 222.35 Y Y Y 
DQ347611 rps11 Ribosomal Protein S11 221.749 Y Y Y 
Y10372 CAPZB 
Capping Protein (Actin 
Filament) Muscle Z-Line, 
Beta 
220.387 Y Y Y 
BC103401 clgn Calmegin 220.011 Y Y Y 
BC114181 DBI 
Diazepam Binding Inhibitor 
(Gaba Receptor Modulator, 
Acyl-Coenzyme A Binding 
Protein) 
219.957 Y Y Y 
M19962 COX5B Cytochrome C Oxidase Subunit Vb 218.769 Y Y Y 
X16978 LOC782270 
Similar To Atp Synthase 
Subunit Epsilon, 
Mitochondrial 
217.565 Y Y Y 
BC108217 Dynlrb2 Dynein, Light Chain, Roadblock-Type 2 215.832 N Y N 
BC102491 LOC281370 Polyubiquitin 215.342 N Y N 
BC126796 C23H6orf129 
Chromosome 6 Open 
Reading Frame 129 
Ortholog 
211.668 N Y N 
BC148017 IMAGE:7946562 Bos taurus ribosomal protein L37, mRNA 208.936 Y Y Y 
BC103060 GABARAP Gaba(A) Receptor-Associated Protein 203.266 N N Y 
BC126795 DEFB123 Defensin, Beta 123 201.937 N Y N 
BC102751 SPATA19 Spermatogenesis Associated 19 201.143 Y Y Y 
BC108162 SEC62 Sec62 Homolog (S. Cerevisiae) 200.111 N N Y 
BC108191 C29H11orf67 Chromosome 11 Open Reading Frame 67 Ortholog 199.775 Y Y Y 
AY835842 H2AFZ Bos taurus histone H2A 
mRNA 197.567 N N N 
BC102469 tmbim6 Transmembrane Bax Inhibitor Motif Containing 6 196.512 N N Y 
BC102286 GNB2L1 
Guanine Nucleotide Binding 
Protein (G Protein), Beta 
Polypeptide 2-Like 1 
196.51 Y Y Y 
BC120462 tspan5 Tetraspanin 5 195.749 Y Y Y 
BC108233 polr2i 
Polymerase (Rna) Ii (Dna 
Directed) Polypeptide I, 
14.5Kda 
195.592 Y Y Y 
BC103314 LOC784243 
Ribosomal Protein L34; 
Similar To Ribosomal 
Protein L34 
195.156 Y Y Y 
BC102445 RpL30 Ribosomal Protein L30 195.066 N Y N 
BC114016 Ccdc54 Coiled-Coil Domain Containing 54 194.483 Y Y Y 
BC102549 Ropn1 Ropporin, Rhophilin Associated Protein 1 193.878 N N Y 
BC109557 meig1 Meiosis Expressed Gene 1 Homolog (Mouse) 193.741 N N Y 
BC111660 LOC526524 
Fk506 Binding Protein 1A, 
12Kda; Fk506 Binding 
Protein 1A, 12Kda-Like 
193.185 Y Y Y 
BC118480 S100G S100 Calcium Binding Protein G 192.026 Y Y Y 
BC118372 SRPK2 Sfrs Protein Kinase 2 190.687 N N Y 
BC109867 DDX25 Dead (Asp-Glu-Ala-Asp) 188.791 N N Y 
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Box Polypeptide 25 
BC108151 Rangrf Ran Guanine Nucleotide Release Factor 188.571 N N Y 
BC116060 capns1 Calpain, Small Subunit 1 187.956 N N Y 
AF520959 Fau 
Finkel-Biskis-Reilly Murine 
Sarcoma Virus (Fbr-Musv) 
Ubiquitously Expressed; 
Similar To Ubiquitin-
Like/S30 Ribosomal Fusion 
Protein 
187.816 N N N 
BC111147 LOC786899 
Similar To Gtpase 
Activating Protein 
Testicular Gap1; 
Hypothetical Loc786899; 
Hypothetical Protein 
Mgc134093 
187.06 Y Y Y 
AB099017 LOC789997 
Similar To 40S Ribosomal 
Protein S3A; Similar To 
Ribosomal Protein S3A; 
Ribosomal Protein S3A; 
Similar To Ribosomal 
Protein S3A 
186.803 Y Y Y 
BC110030 BCAP29 B-Cell Receptor-Associated Protein 29 186.465 Y Y Y 
BC142080 LOC100271685 Membrane-Spanning 4-Domains, Subfamily A-Like 186.038 Y Y Y 
AY911354 LOC785691 
Similar To Mcg10725; 
Ribosomal Protein S25; 
Similar To Ribosomal 
Protein S25 
185.298 Y Y Y 
BC109670 MRPL42 Mitochondrial Ribosomal Protein L42 184.466 Y Y Y 
BC111147 LOC786899 
Similar To Gtpase 
Activating Protein 
Testicular Gap1; 
Hypothetical Loc786899; 
Hypothetical Protein 
Mgc134093 
182.392 Y Y Y 
BC102669 Ppp1r2 
Protein Phosphatase 1, 
Regulatory (Inhibitor) 
Subunit 2 
181.173 N N Y 
AY911347 RpL35A Ribosomal Protein L35A 177.346 Y Y Y 
BC102382 YWHAZ 
Tyrosine 3-
Monooxygenase/Tryptophan 
5-Monooxygenase 
Activation Protein, Zeta 
Polypeptide 
175.813 N N Y 
BC102877 snrpd2 
Small Nuclear 
Ribonucleoprotein D2 
Polypeptide 16.5Kda 
173.477 Y Y Y 
BC110004 PGK2 Phosphoglycerate Kinase 2 173.412 Y Y Y 
AB098832 LOC789997 
Similar To 40S Ribosomal 
Protein S3A; Similar To 
Ribosomal Protein S3A; 
Ribosomal Protein S3A; 
Similar To Ribosomal 
Protein S3A 
173.237 Y Y Y 
GU817014 YWHAZ 
Bos Taurus Tyrosine-3-
Monooxygenase/Tryptophan 
5-Monooxygenase 
Activation Protein Zeta 
Polypeptide 
172.597 Y Y Y 
GU817014 YWHAZ 
Bos Taurus Tyrosine-3-
Monooxygenase/Tryptophan 
5-Monooxygenase 
Activation Protein Zeta 
Polypeptide 
172.597 Y Y Y 
BC126782 LOC100126817 Hypothetical Protein Loc100126817 172.491 Y Y Y 
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DQ347605 LOC782668 Ribosomal Protein L6 171.318 Y Y Y 
BC105179 rpl35 Ribosomal Protein L35 170.04 N N Y 
BC111663 LYRM7 Lyrm7 Homolog (Mouse) 168.54 Y Y Y 
BC102194 EIF5 Eukaryotic Translation Initiation Factor 5 168.115 N N Y 
BC109743 H2AFZ H2A Histone Family, Member Z 166.742 N N Y 
BC118158 IMAGE:8211381 
Bos taurus ST6 (alpha-N-
acetyl-neuraminyl-2,3-beta-
galactosyl-1, 3)-N-
acetylgalactosaminide 
alpha-2,6-sialyltransferase 
2, mRNA 
166.262 Y Y Y 
BT025435 C14orf153 Hypothetical Protein Loc617441 165.939 N N Y 
BC108222 IMAGE:8043996 Bos taurus cDNA clone IMAGE:8043996 165.44 Y Y Y 
DQ677839 C13H20ORF71 Chromosome 20 Open Reading Frame 71 Ortholog 165.204 Y Y Y 
BC108247 SLIRP Sra Stem-Loop-Interacting Rna-Binding Protein 162.812 Y Y Y 
AB099059 rps3 Ribosomal Protein S3 162.118 Y Y Y 
BC102455 LOC786431 
Atp Synthase, H+ 
Transporting, Mitochondrial 
F0 Complex, Subunit G 
160.879 Y Y Y 
AB098994 LOC784528 
Atpase, H+ Transporting, 
Lysosomal 34Kda, V1 
Subunit D 
160.731 Y Y Y 
BC102175 C26H10orf84 Chromosome 10 Open Reading Frame 84 Ortholog 160.09 Y Y Y 
BC109561 Rpl10l Ribosomal Protein L10-Like 159.931 N N N 
BC109732 IMAGE:8059175 Bos taurus cDNA clone IMAGE:8059175 159.464 Y Y Y 
BC111654 RpL35A Ribosomal Protein L35A 158.971 Y Y Y 
BC102313 Rpl27 
Similar To Ribosomal 
Protein L27; Ribosomal 
Protein L27 
158.242 N N N 
BC105143 LOC789244 
Lysophospholipase I; 
Similar To 
Lysophospholipase I 
157.322 N Y N 
DQ347607 LOC509829 
Ribosomal Protein L10; 
Ribosomal Protein L10 
Pseudogene; Similar To 
Ribosomal Protein L10 
157.248 N N N 
BC102970 hsbp1 Heat Shock Factor Binding Protein 1 156.888 Y Y Y 
BC102292 NDUFS4 
Nadh Dehydrogenase 
(Ubiquinone) Fe-S Protein 
4, 18Kda (Nadh-Coenzyme 
Q Reductase) 
156.337 Y Y Y 
BC103431 ELP2P Endozepine-Like Peptide 2 Pseudogene 156.076 N N Y 
BC120463 MGC151969 Uncharacterized Protein Ensp00000334415 Homolog 156.043 N N Y 
AY911366 rps11 Ribosomal Protein S11 155.631 Y Y Y 
S70447 GI:7579921 
F1Fo-ATP synthase 
complex Fo membrane 
domain f subunit 
155.371 Y Y Y 
BC109581 DYDC1 Dpy30 Domain Containing 1 154.473 Y Y Y 
BC111293 LOC780805 Hypothetical Protein Loc780805 152.434 Y Y Y 
BC146140 Dydc2 Dpy30 Domain Containing 2 152.001 N N Y 
DQ347605 LOC782668 Ribosomal Protein L6 151.466 Y Y Y 
AB098890 ORCS10052 
Bos Taurus Mrna For 
Similar To Beta 2-
Microglobulin 
151.332 N N Y 
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X64836 NDUFB9 
Nadh Dehydrogenase 
(Ubiquinone) 1 Beta 
Subcomplex, 9, 22Kda 
149.949 Y Y Y 
BC102593 MORF4L1 
Similar To Morf-Related 
Gene 15; Mortality Factor 4 
Like 1 
149.417 N N Y 
BC109924 Tspan6 Tetraspanin 6 147.491 N Y Y 
BC103363 KPNA2 Karyopherin Alpha 2 (Rag Cohort 1, Importin Alpha 1) 146.212 N N Y 
DQ347612 rps12 Ribosomal Protein S12 144.865 N N Y 
BC103260 CA2 Y Box Binding Protein 1 144.827 N N N 
BC109577 Cetn4 Centrin 4 144.395 Y Y Y 
BC108180 rps21 Ribosomal Protein S21 142.837 N Y N 
BC111609 Iqcf2 Iq Motif Containing F2 142.552 N N Y 
BC102890 Aif1 Allograft Inflammatory Factor 1 141.932 N Y N 
BC109726 C3H1orf189 
Chromosome 1 Open 
Reading Frame 189 
Ortholog 
141.298 Y Y Y 
DQ347592 LOC781370 
Ferritin, Heavy Polypeptide 
1; Similar To Ferritin Heavy 
Chain; Similar To Ferritin, 
Heavy Polypeptide 1 
140.117 Y Y Y 
BC103298 CCT2 Chaperonin Containing Tcp1, Subunit 2 (Beta) 140.009 Y Y Y 
AF265669 RPGRIP1 
Retinitis Pigmentosa Gtpase 
Regulator Interacting 
Protein 1 
139.66 N N Y 
AF164025 RNASE6 Ribonuclease, Rnase A Family, K6 138.861 Y Y Y 
BC102535 TPPP2 
Tubulin Polymerization-
Promoting Protein Family 
Member 2 
138.018 N N Y 
BC102655 LRRC67 Leucine Rich Repeat Containing 67 137.872 Y Y Y 
BC146224 QTRTD1 
Queuine Trna-
Ribosyltransferase Domain 
Containing 1 
137.523 N N N 
BC148911 TRDN Triadin 137.457 N N N 
BC111170 C10H15orf23 Chromosome 15 Open Reading Frame 23 Ortholog 137.17 N N Y 
BC111202 ilf2 Interleukin Enhancer Binding Factor 2, 45Kda 136.727 N N Y 
BC108198 PRM3 Bos taurus protamine 3, 
mRNA 136.117 N N N 
BC102492 LOC616936 Male-Enhanced Antigen 1 135.939 N N N 
BC102230 Rnf181 Ring Finger Protein 181 135.888 N N N 
BC102391 PSMC2 
Proteasome (Prosome, 
Macropain) 26S Subunit, 
Atpase, 2 
135.115 N Y N\ 
BC103021 LOC785297 Ferritin, Light Polypeptide 134.371 Y Y Y 
BC110226 C20orf111 Hypothetical Protein Loc510457 134.345 N N Y 
AY911377 LOC785455 
Similar To Thymosin, Beta 
4; Thymosin Beta 4, X-
Linked 
134.314 N N Y 
BC111643 IMAGE:8018076 Bos taurus cDNA clone IMAGE:8018076 134.23 N N Y 
BC140514 CSDE1 Cold Shock Domain Containing E1, Rna-Binding 134.098 Y Y Y 
BC102325 ARL4A Adp-Ribosylation Factor-Like 4A 133.928 N N N 
AF013213 LOC789867 Eukaryotic Translation Elongation Factor 1 Alpha 1 133.722 Y Y Y 
BC119912 C22H3ORF19 Chromosome 3 Open Reading Frame 19 Ortholog 132.945 Y Y Y 
BC114202 SON Son Dna Binding Protein 132.028 Y Y Y 
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BC114038 LOC540061 Hypothetical Loc540061 131.713 Y Y Y 
BC109696 Image:8061225 Bos Taurus Cdna Clone Image:8061225 131.694 N N Y 
DQ347583 myl6 
Myosin, Light Chain 6, 
Alkali, Smooth Muscle And 
Non-Muscle 
131.028 Y Y Y 
BC112612 Dnajc5b 
Dnaj (Hsp40) Homolog, 
Subfamily C, Member 5 
Beta 
130.665 Y Y Y 
X64897 Ndufa4 
Nadh Dehydrogenase 
(Ubiquinone) 1 Alpha 
Subcomplex, 4, 9Kda 
130.65 N N Y 
BC109715 MGC:134272 Bos taurus cDNA clone MGC:134272 130.387 N N N 
X64898 LOC781609 
Nadh Dehydrogenase 
(Ubiquinone) 1 Beta 
Subcomplex, 4, 15Kda 
130.066 Y Y Y 
AY911370 LOC786773 Ribosomal Protein L26 129.524 Y Y Y 
BC114805 SPATA3 Spermatogenesis Associated 3 129.437 N N Y 
BC102311 FILIP1L Filamin A Interacting Protein 1-Like 129.251 N N Y 
AY911320 Cox7c Cytochrome C Oxidase Subunit Viic 128.463 Y Y Y 
BT021019 Naca 
Nascent Polypeptide-
Associated Complex Alpha 
Subunit; Similar To 
Nascent-Polypeptide-
Associated Complex Alpha 
Polypeptide 
127.487 Y Y Y 
AF100170 AKAP4 A Kinase (Prka) Anchor Protein 4 126.623 Y Y Y 
BC120019 MLLT11 
Myeloid/Lymphoid Or 
Mixed-Lineage Leukemia 
(Trithorax Homolog, 
Drosophila); Translocated 
To, 11 
126.453 N Y N 
BC122782 LOC781500 Hypothetical Protein Loc781500 126.357 N N Y 
BT030513 Rpn2 Ribophorin Ii 126.355 Y Y Y 
AB099075 LOC784061 
Similar To 60S Ribosomal 
Protein L21; Similar To 
Ribosomal Protein L21; 
Ribosomal Protein L21 
125.979 Y Y Y 
BC120104 C1H3orf38 Chromosome 3 Open Reading Frame 38 Ortholog 125.625 Y Y Y 
BC140633 IMAGE:8190785 
Bos taurus platelet-
activating factor 
acetylhydrolase, isoform Ib, 
alpha subunit 45kDa, 
mRNA 
125.591 Y Y Y 
BC105172 STON1-GTF2A1L Ston1-Gtf2A1L Readthrough Transcript 125.133 Y Y Y 
BC102090 rps3 Ribosomal Protein S3 124.907 N N N 
AB099047 LOC531679 Ribosomal Protein 17-Like 123.815 N Y N 
AB434936 TERF2 Telomeric Repeat Binding Factor 2 123.541 Y Y Y 
BC108202 ube2b 
Ubiquitin-Conjugating 
Enzyme E2B (Rad6 
Homolog) 
123.39 N N Y 
BC109731 C16H1orf100 
Chromosome 1 Open 
Reading Frame 100 
Ortholog 
123.238 Y Y Y 
BC111270 srp54 Signal Recognition Particle 54Kda 123.224 Y Y Y 
BC126821 Upf2 
Upf2 Regulator Of 
Nonsense Transcripts 
Homolog (Yeast) 
122.278 N N N 
AF144764 timp2 Timp Metallopeptidase 121.825 N N N 
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Inhibitor 2 
BC102670 MGC127695 Hypothetical Protein Mgc127695 121.633 Y Y Y 
BC148013 RPL14 Bos Taurus Ribosomal Protein L14 120.553 Y Y Y 
BC112887 IMAGE:8009582 
Bos taurus ribosomal 
protein S27 
(metallopanstimulin 1), 
mRNA 
120.098 N N N 
BC110187 fhl5 Four And A Half Lim Domains 5 119.147 Y Y Y 
BC116058 KCMF1 Potassium Channel Modulatory Factor 1 118.853 N N Y 
DQ347593 LOC781370 
Ferritin, Heavy Polypeptide 
1; Similar To Ferritin Heavy 
Chain; Similar To Ferritin, 
Heavy Polypeptide 1 
117.121 Y Y Y 
AB098931 rps8 Ribosomal Protein S8 116.998 N N Y 
BC109560 LOC784487 
Ribosomal Protein L7; 
Similar To Ribosomal 
Protein L7; Similar To 60S 
Ribosomal Protein L7 
116.859 N Y N 
BC109745 LOC528549 
Similar To Dnaj (Hsp40) 
Homolog, Subfamily B, 
Member 3 
116.751 N N N 
BC150005 LSM2 
Lsm2 Homolog, U6 Small 
Nuclear Rna Associated (S. 
Cerevisiae) 
116.734 N N Y 
BC111147 LOC786899 
Similar To Gtpase 
Activating Protein 
Testicular Gap1; 
Hypothetical Loc786899; 
Hypothetical Protein 
Mgc134093 
116.682 Y Y Y 
BC103454 mrps36 Mitochondrial Ribosomal Protein S36 116.104 Y Y Y 
AB098752 LOC782525 
Eukaryotic Translation 
Elongation Factor 1 
Gamma; Similar To 
Eukaryotic Translation 
Elongation Factor 1 Gamma 
116.059 Y Y Y 
BC110254 TES 
Testis Derived Transcript (3 
Lim Domains); Similar To 
Testis Derived Transcript 
115.614 N N N 
BC111209 pdhA2 Pyruvate Dehydrogenase (Lipoamide) Alpha 2 114.458 N N Y 
BC109677 FXR1 
Fragile X Mental 
Retardation, Autosomal 
Homolog 1 
114.322 Y Y Y 
BC116167 FAIM2 Fas Apoptotic Inhibitory Molecule 2 112.984 N N Y 
BC112616 Trim59 Hypothetical Loc540154 112.836 Y Y Y 
BC102601 ropn1l Ropporin 1-Like 112.278 N N Y 
BC105363 YBX1 Y Box Binding Protein 1 112.262 N N Y 
BC146060 THAP7 
Tubulin, Alpha 1A; Tubulin, 
Alpha 1B; Similar To 
Alpha-Tubulin I; Thap 
Domain Containing 7 
112.181 N N N 
AF541971 DDX4 Dead (Asp-Glu-Ala-Asp) Box Polypeptide 4 111.38 Y Y Y 
BC114188 LOC507141 Ce5 Protein-Like 110.65 Y Y Y 
BC108246 MGC133632 Hypothetical Protein Loc614279 110.389 N N Y 
BC110170 CSNK2B Casein Kinase 2, Beta Polypeptide 110.244 N N Y 
BC109563 TRYX3 Trypsin X3 110.204 Y Y Y 
BC102081 DAD1 Defender Against Cell Death 1 110.078 Y Y Y 
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X55389  F1-ATPase mRNA for F1-ATPase gamma-subunit 110.066 N N Y 
BC109599 ADORA3 Adenosine A3 Receptor 109.351 Y Y Y 
BC102328 SNRPB2 
Small Nuclear 
Ribonucleoprotein 
Polypeptide B'' 
109.087 N N Y 
BC109851 Asb17 Ankyrin Repeat And Socs Box-Containing 17 108.906 Y Y Y 
BC108243 NDUFA5 
Nadh Dehydrogenase 
(Ubiquinone) 1 Alpha 
Subcomplex, 5, 13Kda 
108.605 Y Y Y 
AY911358 LOC781565 Ribosomal Protein S6 108.563 Y Y Y 
BC110237 Mlec Malectin 108.544 N N Y 
BC110212 LOC786673 
Atp Synthase, H+ 
Transporting, Mitochondrial 
F0 Complex, Subunit B1 
108.505 Y Y Y 
BC109625 Gkap1 G Kinase Anchoring Protein 1 108.462 Y Y Y 
BC140615 ADAM3A Adam Metallopeptidase Domain 3A (Cyritestin 1) 108.146 Y Y Y 
BC102873 Fau 
Finkel-Biskis-Reilly Murine 
Sarcoma Virus (Fbr-Musv) 
Ubiquitously Expressed; 
Similar To Ubiquitin-
Like/S30 Ribosomal Fusion 
Protein 
108.13 N N N 
BC102656 IMAGE:30956887 Bos taurus pituitary tumor-transforming 1, mRNA 107.717 Y Y Y 
AB373012 CYP1B1 
Cytochrome P450, Family 
1, Subfamily B, Polypeptide 
1 
107.159 Y Y Y 
BC102135 BZW1 Basic Leucine Zipper And W2 Domains 1 105.11 Y Y Y 
BT030749 LOC506261 
Similar To 14-3-3 Protein 
Theta (14-3-3 Protein Tau) 
(14-3-3 Protein T-Cell) 
(Protein Hs1) 
105.009 N N Y 
BC111628 IMAGE:8019171 Bos taurus cDNA clone IMAGE:8019171 104.983 Y Y Y 
BC109721 INSL6 Bos taurus insulin-like 6, 104.965 N N Y 
BC126695 KLHL10 Kelch-Like 10 (Drosophila) 104.86 N N Y 
BC112511 VTI1B 
Vesicle Transport Through 
Interaction With T-Snares 
Homolog 1B 
103.334 N N Y 
BC102885 Paip2 Poly(A) Binding Protein Interacting Protein 2 103.312 N N N 
AB098765 FTH1 mRNA for similar to ferritin H subunit 103.092 N N Y 
BC108215 RTF1 Rtf1, Paf1/RNA polymerase II complex component 102.78 N N Y 
BC111179 PSMG2 
Proteasome (prosome, 
macropain) assembly 
chaperone 2 
102.639 N Y N 
BC133582 cnot1 Ccr4-Not Transcription Complex, Subunit 1 102.582 Y Y Y 
BC109747 Hemgn Hemogen 102.453 Y Y Y 
AB098753 LOC781609 Similar To B15 Subunit Of The NADH 102.178 Y Y Y 
BC102499 naa38 
Lsm8 Homolog, U6 Small 
Nuclear Rna Associated (S. 
Cerevisiae) 
100.954 N N Y 
BC109698 FUNDC2 FUN14 domain containing 2 100.902 N N Y 
HQ423186 BBD126 Bos Taurus Beta-Defensin 126 Mrna 100.859 Y Y Y 
AF307320 RPS28 ribosomal protein S28-like protein mRNA 100.799 N N N 
BC109495 WDR61 WD repeat domain 61 100.679 N N Y 
BC102453 STMN1 Stathmin 1/oncoprotein 18 100.645 N N Y 
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BC126794 LYZL1 Lysozyme-Like 2 100.291 Y Y Y 
BC112727 CCDC91 Coiled-coil domain 
containing 91 100.177 N N Y 
 
 
  
75 
 
CHAPTER 3: MOLECULAR REPRODUCTION AND DEVELOPMENT 
MANUSCRIPT 
Title: Are full-length mRNA in Bos taurus spermatozoa transferred to the oocyte 
during fertilization? 
 
Authors:  Anderson EJ1, Card C1, Sartini BL1,3 
 
1Department of Fisheries, Animal and Veterinary Science, University of Rhode Island, 
Kingston, Rhode Island 02881 
 
3Corresponding author: BL Sartini, 179 Center for Biotechnology and Life Sciences, 
120 Flagg Road, University of Rhode Island, Kingston, RI 02886, Phone: 401-874-
2667, FAX: 401-874-7575, Email: blsartini@uri.edu. 
 
Institution at which work was performed: University of Rhode Island, Kingston, RI 
 
Short Title:  Full-Length mRNA in Bull Spermatozoa 
 
Key Words (3-6): Spermatozoa, full-length, mRNA 
 
Abbreviations: mRNA = messenger RNA; FPKM = Fragments Per per Kilobase of 
transcript per Million mapped reads; RNA-Seq = ribonucleic acid sequencing; rRNA 
= ribosomal ribonucleic acid; CR = conception rate; PCR = polymerase chain reaction; 
UTR = untranslated region 
 
76 
 
Grant Support: This project was supported by an Agriculture and Food Research 
Initiative Competitive Grant no. 2011-67016-20073 from the USDA National Institute 
of Food and Agriculture to BLS. This research is based in part upon work conducted 
using the Rhode Island Genomics and Sequencing Center which is supported in part 
by the National Science Foundation under EPSCoR Grants Nos. 0554548 & EPS-
1004057. 
77 
 
Abstract:  
Spermatozoa are now known to contain a limited number of mRNAs and the 
contribution of these mRNAs to early embryonic development has been controversial. 
Although the spermatozoal transcript profile contains a predominance of degraded 
transcripts, only full-length mRNA transcripts will be capable of producing a protein 
after the spermatozoa fertilize the oocyte and the presence of full-length spermatozoal 
transcripts has not been investigated. This study sequenced 24 spermatozoal 
transcripts, chosen using four techniques: high FPKM within an RNA-Seq dataset, 
Gene Ontology of the RNA-Seq dataset, Y chromosome specificity, and transcripts 
discovered from previous studies, to determine if full-length transcripts exist in 
spermatozoa.   Of these transcripts, 16 were full-length, while 8 are degraded. 
Additionally, four transcripts, PSMA6, ATPase β, CHMP5, and DDX3Y, have 
alternative polyadenylation sites, which the referenced RNA-Seq study failed to 
identify. To further characterize the potential functionality of these transcripts, the 
transfer of spermatozoal transcripts to oocytes and 2-cell stage embryos was 
examined. However, recurrent contamination and conflicting results from the oocyte 
and 2-cell embryos occurred.  Despite this, the 16 transcripts that have been found to 
be full-length in spermatozoa do merit further investigation, and prove that while 
many transcripts are degraded remnants from spermatogenesis, full-length mRNAs, 
with the potential to be a functional protein, are found in spermatozoa.   
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Introduction:  
Recent research has shown that spermatozoa contain not only genomic DNA, 
but also a subset of mRNA (Lalancette et al. 2008; Avendaño et al. 2009; Johnson et 
al. 2011; Card et al. 2013). Although spermatozoa are not transcriptionally or 
translationally active, they still contain mRNAs present from the final surge of 
transcriptional activity at the end of spermatogenesis (Miller and Ostermeier 2006; 
Boerke et al. 2007).   Many of the transcripts found in spermatozoa are degraded 
(Gilbert et al. 2007), although functional roles of spermatozoa mRNAs have been 
proposed, including functions in early embryo development regulation, epigenetic 
modifications, paternal genome maintenance, and structural functions (Lalancette and 
Miller 2008). Spermatozoal mRNAs are likely most important prior to the transition 
from maternal to zygotic gene expression, since this is when they are most capable of 
affecting gene expression and epigenetic regulation. In cows, a transcriptional burst 
occurs at the eight to sixteen-cell embryonic stage, when zygotic control of mRNA 
expression begins (Vigneault et al. 2009). This activation occurs approximately 62 
hours after fertilization, so any transcripts carried by the spermatozoa provide an 
advantage since there is little time for transcription and translation to occur before the 
zygote takes control of the mRNA expression (Memili and First 2000).   
A role for sperm-derived RNAs after fertilization is supported by a functional 
role for microRNA-34c during the first cleavage of mouse embryos (Liu et al. 2012). 
Micro-RNAs may also have an epigenetic impact on the embryo (Carrell and 
Hammoud 2010). To date, PLC- ζ is the only sperm-derived mRNA with a known 
function in the oocyte after fertilization.  PLC- ζ triggers the Ca2+ oscillations during 
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oocyte activation (Swann et al. 2006; Hamatani 2012), and may also have a role in 
embryo cell-signaling (Boerke et al. 2007). 
Limited studies have demonstrated that other spermatozoal transcripts can be 
detected in embryos, but are not present in oocytes, including AKAP 4, CLGN, CLU, 
DDX3Y, PLC-ζ, PRM1, PRM2 SPAG9, and SRY (Suri 2004; Boerke et al. 2007; 
Kempisty et al. 2008b). Of particular interest to this study are genes that are 
spermatozoa-specific, as they will be most useful for downstream protein 
identification in the embryo. The use of Y-chromosome specific transcripts allows for 
definitive identification of heritage of the transcript from the spermatozoa, an example 
transcript is DDX3Y (Sekiguchi et al. 2004; Vong et al. 2006; Bermejo-Alvarez et al. 
2010; Yao et al. 2010a; Yao et al. 2010b). DDX3Y, a DEAD-box RNA helicase that 
can change RNA secondary structure, is sperm-derived but found in the embryo at 
fertilization (Yao et al. 2010a).  A reduction in sperm-derived DDX3Y mRNA 
decreases embryonic development rates therefore a role for sperm-derived DDX3Y in 
early embryogenesis has been proposed (Abdelhaleem 2005; Yao et al. 2010b).  
However, previous research has identified individual spermatozoal transcripts 
primarily using microarrays that detect only a small segment of a transcript and cannot 
determine if a full-length transcript is present.  Although a large proportion of 
spermatozoal transcripts are degraded, but they may still be used as predictors of bull 
fertility (Gilbert et al. 2007; Bissonnette et al. 2009). No previous research has 
investigated if spermatozoal mRNAs are full-length, including the coding region and 
untranslated regions, despite the fact that incomplete mRNAs will be incapable of 
producing proteins used in embryo development. Identifying full-length transcripts 
80 
 
may allow further studies to elucidate if these transcripts have a functional role in the 
embryo or are degraded in the embryo.  
We hypothesize that full-length mRNAs are present in spermatozoa and some 
may be transferred to the oocyte and detected in the early embryo after fertilization.  
In this study, candidate spermatozoal transcripts were identified from the transcript 
profile of bull spermatozoa sequenced by RNA-Seq (Card et al. 2013). Transcripts 
were identified using four techniques: 1)if they had high FPKMs in the RNA-Seq 
dataset, 2) found in Gene Ontology (GO) categories of interest, 3) located on the Y 
chromosome, or 4) present in previous literature. With RNA-Seq, potential full-length 
transcripts can be identified by alignment of sequenced fragments to the bovine 
genome.  Potentially functional spermatozoal transcripts were also identified by 
comparing microarray data from oocyte and embryo studies (Kocabas et al. 2006; 
Chalmel et al. 2007; Huang and Khatib 2010).  
Additionally, this work highlights some specific examples of alternative 3’ 
ends for transcripts that are found in spermatozoa, and provides quantitative percent 
coverage of several transcripts. Identification of full-length spermatozoal transcripts 
that are transferred to the oocyte at fertilization could be used in further functional 
studies.  
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Materials and Methods: 
Spermatozoal transcript selection 
Four approaches were used to identify select candidate bovine spermatozoal 
transcripts for further analysis to determine if these transcripts are full-length in 
spermatozoa and if these transcripts are transferred to the oocyte at fertilization (Table 
1).  The first three approaches mined the bovine spermatozoa transcript profile (Card 
et al. 2013) and the same pool of bovine spermatozoa from nine bulls was used in both 
studies to validate full-length transcripts.  In the first approach, we identified nine 
spermatozoal transcripts with high FPKMs (fragments per kilobase million mapped 
reads) in the bovine spermatozoal transcript profile (Card et al. 2013).  In the second 
approach, we identified transcripts in the top Gene Ontology (GO) category, 
translation (Card et al. 2013). Third, Y chromosome specific transcripts in the bovine 
spermatozoal transcript profile were identified because it is a definitive way to prove 
that the transcript was sperm-derived in embryo. Finally, thirteen potentially 
functional spermatozoal transcripts from previous studies were confirmed present the 
bovine spermatozoa transcript profile.   
To determine if any of the selected transcripts were potentially transferred to 
the oocyte by the spermatozoa, previous microarray studies were used to find 
transcripts that were previously present in spermatozoa (Chalmel et al. 2007) but 
absent in the oocyte (Kocabas et al. 2006).  
Tissue Samples 
Bovine testes were collected from a local abatoir for RNA isolation. Bovine 
cumulus-free oocytes and two-cell stage embryos were obtained from Sexing 
82 
 
Technologies (Navasota, TX).  Cryopreserved bovine spermatozoa straws were 
obtained from Genex Cooperative Inc., (Shawano, WI).  Spermatozoa from nine 
individual bulls was pooled after RNA isolation (see below) for cDNA amplification. 
These individuals had Conception Rate (CR) scores ranging from -2.9 to 3.5.  
Spermatozoa from an additional three bulls were used for mRNA Reverse 
Transcription (RT) for use in 5’ and 3’ Rapid Amplification of cDNA Ends (RACE) 
protocols. The three bull spermatozoa pool has CR scores of -0.3, 1.3, and -4.  
Tissue RNA Isolations 
RNA was isolated from bovine testis and spermatozoa using TRIzol isolation 
(Sigma-Aldritch; St. Louis, MO). Testis RNA isolations were performed according to 
manufacturer’s instructions, using 100 mg of tissue per isolation.  
Spermatozoa TRIzol isolations were modified from the kit protocol as 
described in Card and Anderson et al. 2013. After washing spermatozoa with PBS 
(Phosphate Buffered Saline) to remove the cryoprotectant, 1 mL TRIzol with 15 
µg/mL glycogen was added to the sperm.  Samples were then lysed using a 26g needle 
and incubated at room temperature for thirty minutes.  Then chloroform was added 
and incubated for 10 minutes at room temperature. Phase separation was done at 
12000 x g for 15 minutes at 4° C. The aqueous layer was removed, combined with 500 
µL ice-cold isopropanol, and chilled on ice for 10 minutes. After a 12000 x g 
centrifugation for 10 minutes, , the precipitated pellet washed with 1 mL 75% ethanol 
and centrifuged for an additional 10 minutes. Supernatant was removed, and pellet 
was air dried. The pellet of RNA was then resuspended in nuclease free water. RNA 
samples were DNAse treated using the RNeasy Mini Kit (Qiagen, Valencia, CA), and 
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RNA concentrations were measured using the NanoDrop UV/Vis spectrometer 
(Thermo Scientific; Wilmington, DE). Samples were then stored at -80°C.  
 Bovine oocyte and 2-cell stage embryo RNA isolations were performed 
according to manufacturer’s instructions, using the PicoPure RNA isolation kit 
(Arcturus, Mountain View, CA), with 40 oocytes or embryos used per isolation.  
RACE Reverse Transcription and Polymerase Chain Reaction (RACE RT-PCR) 
RACE RT-PCR was used for amplification of 5’ and 3’ ends of transcripts, 
using the three bull spermatozoa pool. For transcripts <1200 bp, the full-length 
transcripts was amplified using this technique. RT-PCR 5’ and 3’ RACE protocols 
were performed according to manufacturer’s instructions (Invitrogen, Carlsbad, CA), 
using a Gene Specific Primer (GSP) (Table 2) paired with a Generacer 5’ or 3’ 
universal primer for improved amplification of the poly(A) tail and 5’ Untranslated 
Region (UTR). Transcripts that were <1200 base pairs were amplified using primers 
spanning from the 5’ exon to the 3’ exon, with a 5’ RACE and a 3’RACE PCR run in 
conjunction to amplify all areas as necessary. For transcripts with >1200 base pairs, 
overlapping amplicons were used to cover the entirety of the transcript.   
Primers were designed for use with 5’ and 3’ RACE RT-PCRs to amplify ends 
of transcripts. Additional primer sets for each transcript of interest were designed to 
provide overlapping amplicons for sequencing of the midsection of each transcript, 
and when transcripts were larger than 1200 base pairs, additional standard RT-PCRs 
(discussed below) were used to amplify regions spanning the exons from the 5’ end to 
the 3’ end. Each primer set was tested on testis RNA as a positive control. 
Additionally, a negative control lacking template was run in parallel. 
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cDNA Amplification & Standard RT-PCR 
Due to low yield from spermatozoa RNA isolations, amplified ds-cDNA from 
a nine bull pool was used for PCR for transcripts with >1200 bp. RNA was converted 
to ds-cDNA and amplified before use in PCR reactions (SMARTer Pico PCR cDNA 
Synthesis Kit; Clontech, Mountain View, CA). The cDNA amplification enriches for 
full-length mRNA populations by using a modified oligo(dT) primer. All PCRs were 
run for 26 cycles to optimize them to reach the linear phase. Each of the nine bulls was 
equally represented in the final pooled sample. PCRs were performed under standard 
conditions as follows: 1X reaction buffer, 1.5 mM MgCl2, 10 mM dNTPs, 2.5 µM 
forward and reverse primers (Table 2), and 2.5 U Taq polymerase (NEB, Ipswich, 
MA). PCRs were run under standard temperatures of: 94°C for 5 min, 35 cycles of 
94°C for 30 sec, primer dependent annealing temperature for 30 sec then 72°C for 2 
min followed by a final extension at 72°C for 10 min. All PCRs were run with a 
positive Testis RNA control and a negative control without template RNA.  
Oocytes and two cell stage embryos were amplified in two separate sets. The 
first set was cDNA amplified into ds-cDNA using the SMARTer Pico PCR cDNA 
Synthesis Kit (Clontech, Mountain View, CA). The second set was performed using 
the standard RT-PCR conditions described above. All RT-PCRs were run with a 
positive testis control and a negative no template RNA control.  
Agarose Gels & Sequencing 
PCR products were visualized on a 2.0% agarose gel stained with ethidium 
bromide, and run by gel electrophoresis. Bands excised from the gel were gel purified 
(Qiagen Gel Extraction kit; Valencia, CA), and submitted for sequencing at the URI 
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Genomics Center (Kingston, RI). Amplicon sequence identity was confirmed by 
submission to NCBI BLAST and by alignment to the original transcript accession the 
primers were designed from.   
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Results:  
Twenty-four spermatozoal transcripts were chosen for this study from previous 
spermatozoal transcript studies, a spermatozoal RNA-Seq dataset, and for their male 
specificity (Table 1).  Transcripts were chosen if visual inspection of the RNA-Seq 
read mappings using the UCSC browser showed that exons were present in the RNA-
Seq analysis (Figure 1; Meyer et al. 2013). Only two transcripts were selected using 
the Gene Ontology selection method from the translation category, EEF1G and 
EEF1A1. Additional transcripts that did not show complete exon mapping were also 
chosen for analysis if previous studies had hypothesized a function for these 
transcripts including the Y chromosome transcript, DDX3Y.  DDX3Y was the only Y 
chromosome spermatozoa transcript identified. This is not entirely unexpected, as the 
Y-chromosome contains only 33 genes in total (Yao et al. 2010b).  
Of the selected candidate spermatozoal transcripts examined, the full-length of 
16 spermatozoal transcripts were PCR amplified for the genes CCT8, H2AFZ, 
COX7A2, CRISP2, EEF1A1, EEF1G, GSTM3, PLCZ1, PRM1, PSMA1, HMGB4, 
GTSF1, CKS2, PSMA6, SEC61G, and CMYC (Figure 2). Transcripts were considered 
to be full-length when they contained greater than 90% sequencing coverage, although 
the transcripts CCT8, COX7A2, CRISP2, EEF1A1, EEF1G, GSTM3, PRM1, and 
PSMA1 have been 100% sequenced (Table 3A).  
Eight additional transcripts could not be sequenced in entirety, most likely 
because they are degraded in spermatozoa (Figure 1B). These eight transcripts found 
in the bovine spermatozoal transcript RNA-Seq data had similar missing regions in 
PCR amplifications (Figure 3; Table 3). An example of this is the transcript PEBP1, 
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which had read mappings missing from the 5’ end exon entirely; corresponding to 
missing reads found using PCR amplification (Figure 1). Five transcripts, PEBP1, 
ATPase B, CHMP5, UBE2N, and DDX3Y, were found to be non-full-length in both the 
RNA-Seq data and in PCR identification.   
A distinguishing characteristic that was found when sequencing full-length 
transcripts was evidence of alternative 3’ untranslated regions (UTRs) in novel 
locations to previous accessions. Although accessions for mRNA transcripts may be 
labeled for a single gene, there may be multiple isoforms or variants of a transcript 
that exist. Four transcripts, PSMA6, ATPase β, CHMP5, and DDX3Y, had alternative 
3’ UTRs (Figures 1 and 2; Table 3). These transcripts were degraded, with the 
exception of PSMA6, which was shown to be full-length.  
The transcripts chosen for amplification in oocytes and 2-cell stage embryos 
were identified as transferred to the embryo from spermatozoa in a different species or 
because these transcripts were not present in microarray studies of oocytes 
(Ostermeier et al. 2004; Kocabas et al. 2006; Chalmel et al. 2007; Kempisty et al. 
2008a). Transcripts found to be present in oocytes from previous microarray data were 
eliminated for further analysis, since PCR will be incapable of distinguishing the 
origin of the mRNAs in the zygote (Table 4). This left nine transcripts to investigate 
further that were absent in the oocyte microarray data: AKAP4, CLGN, CMYC, 
CRISP2, DDX3Y, HMGB4, PLCZ1, PRM1, and SPA17.  
Contamination and conflicting results from PCR amplification of spermatozoal 
transcripts in oocytes and 2-cell embryos have yielded inconclusive results. Two 
replicates of oocytes and 2-cell embryos pools, one cDNA amplified and one 
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unamplified RNA, have demonstrated amplification of male-specific transcripts in 
female tissue, for example DDX3Y and PRM1 (Figure 4).   
Discussion:  
Visual inspection of RNA-Seq reads mapped to the bovine genome from the 
bovine spermatozoa transcript profile was used to identify sixteen full-length 
transcripts and these were validated by PCR amplification and subsequent sequencing, 
proving that these transcripts have the basic potential for use downstream in the early 
stage embryo.  These results validate RNA-Seq read mappings by directly sequencing 
the 5’ and 3’ UTRs in addition to the complete protein coding region of these 
transcripts.  Importantly, PCR sequencing is capable of identifying transcripts that 
have been alternatively polyadenylated, which may impact the timing of translation, 
while RNA-Seq cannot. Additionally, if multiple isoforms of a transcript are present, 
they can be detected through PCR more accurately than with RNA-Seq.   Studies of 
this nature that use both RNA-Seq and PCRs may prove useful as prerequisite 
identification of targets for determining if these transcripts are translated into protein 
in the embryo.   
While other studies have looked at the mRNAs contained in spermatozoa, this 
is the first study to identify full-length transcripts. The importance of this is noted by 
the fact that this study found transcripts of interest from previous literature (Table 1) 
that are not full-length (Table 3), and therefore likely non-functional. An example of 
this is DDX3Y, which has been examined in previous studies. One study found that 
reduction in sperm-derived DDX3Y mRNA has a role in spermatogenesis 
(Abdelhaleem 2005). A second study found that DDX3Y was transferred from mouse 
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spermatozoa to the oocyte and that it’s absence decreases embryo development rates 
(Yao et al. 2010a).  Although these previous studies point to a role for DDX3Y, it was 
degraded in the spermatozoa transcript population reported here and therefore could 
not be functional as a translational template in the embryo.  The mRNA transcript 
AKAP4 which was found to be degraded in this studies transcript profile correlates 
with its known function as a a regulator of spermatozoa motility (Miki et al. 2002). 
However, the use of these degraded transcripts may still serve as indicators of fertility, 
despite knowing that a particular degraded transcript will not have a functional use in 
the oocyte (Lalancette et al. 2008).   
     The transcripts found to be full-length in this study will be useful candidates 
for examination of protein function in future studies to determine if sperm-derived 
mRNA does have a functional role in early embryogenesis.   Spermatozoal mRNAs 
are likely most important prior to the transition from maternal to zygotic gene 
expression, since this is when they are most capable of affecting gene expression and 
epigenetic regulation. In cows, a transcriptional burst occurs at the eight to sixteen-cell 
stage, when zygotic control of mRNA expression begins (Vigneault et al. 2009). This 
activation occurs around 62 hours after fertilization, so any transcripts carried by the 
spermatozoa provide an advantage since there is little time for transcription and 
translation to occur before the zygote takes control of the mRNA expression (Memili 
and First 2000).  To date, the only full-length spermatozoal transcript known to have 
an embryonic function is PLC- ζ.  PLC- ζ triggers the Ca2+ oscillations during mouse 
oocyte activation and may have a role in embryo cell-signaling (Swann et al. 2006; 
Boerke et al. 2007; Hamatani 2012).  This study was able to demonstrate that PLC- ζ 
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is full-length, although it is unable to confirm that PLC- ζ is delivered to the oocyte 
during bovine fertilization.   
Other full-length spermatozoal transcripts that were identified in this study are 
known to rapidly degrade after entering the oocyte, including PRM1, indicating no 
further functionality within the embryo (Avendaño et al. 2009; Thelie et al. 2009). 
Furthermore, this study does not indicate the degree of degradation that might occur to 
the spermatozoal transcripts once they reach the oocyte.  To further explore how much 
degradation occurs and when it occurs, future studies will need to explore oocytes and 
embryos to trace the inheritance of these spermatozoal mRNAs.  
Full-length spermatozoal transcripts were sequenced that warrant further 
functional experiments. For example, CRISP2 may assist with spermatozoa survival in 
the female tract and fertilization (Arangasamy et al. 2011). Preliminary reports of 
translation occurring in the spermatozoa mitochondria may indicate a need to replace 
proteins necessary for fertilization, as this translation occurs in the spermatozoa 
tailpiece right after the spermatozoa undergo capacitation (Gur and Breitbart 2008).   
An additional hypothesized function of spermatozoal mRNA is an epigenomic 
effect on embryonic development. Although the degree of epigenetic influence that the 
spermatozoal mRNAs exhibit is unknown, genes such as PRM1 and H2AFZ have been 
shown to have an influence on the epigenome (Jenkins and Carrell 2012). Specifically, 
sperm-specific PRM1 proteins replace histones in spermatozoa chromatin, regulating 
how development proceeds (Carrell and Hammoud 2010). PRM1 may act to 
selectively unwind specific regions of the paternal DNA to make it more accessible for 
transcription and translation in the early embryo before being degraded (Miller et al. 
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2005).  The transcript H2AFZ is an effector of gene regulation as well by acting as a 
histone modifier (Misirlioglu et al. 2006). By demonstrating that PRM1 and H2AFZ 
are full-length in spermatozoa, this study demonstrates the potential for spermatozoa 
to have an epigenetic effect on embryonic development.  
However, it is important to highlight the inherent bias to these selection 
methods, with a clear focus on isolating genes with a high probability of being full-
length. This study cannot be used to comment on the percentage of transcripts that 
may be full-length in the spermatozoa, only to prove that some do exist.  
This study is incapable of determining if full-length spermatozoal transcripts 
are transferred to the oocyte at fertilization. The attempted oocyte and 2-cell embryo 
PCRs yielded inconclusive results. Several suspect amplifications indicated that the 
oocytes and 2-cell embryos were likely contaminated in both the cDNA amplified and 
unamplified RNA experiments (Figure 4).  The presence of known sperm-specific 
transcripts and Y chromosome transcripts in these populations, as well as varying 
results from gel to gel (Figure 4), make it impossible to conclude more about the 
spermatozoa to oocyte inheritance of these transcripts at this time. 
In conclusion, full-length transcripts have been definitively proven to exist 
within bull spermatozoa, lending credence to the potential function of these mRNAs 
within the oocyte and embryo. Global comparisons of oocyte and embryo transcripts 
to spermatozoal transcripts are also needed to further identify targets that may be 
translated into proteins and impact embryogenesis.  
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Figures 
 
Figure 1: Alignment of spermatozoa transcript RNA-Seq reads (bottom line) with 
bovine genome in UCSC Mappings (Meyer et al. 2013) using bovine spermatozoa 
RNA-Seq data from (Card et al. 2013) for bovine spermatozoa transcripts assayed in 
this study.  Untranslated Regions (UTRs) are included in all transcripts shown here as 
thinner black lines at both ends of each transcript.  RNA-Seq mappings don’t show 
separate UTRs and have a continuous thick black line.  Summary of read mappings 
indicating full-length (all exons mapped) or degraded transcripts (exons missing) is 
indicated on the right.   Extra exons sequenced in RNA-Seq but not visualized in the 
bovine genome are also indicated. 
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Figure 2: Full-length bovine spermatozoal transcripts   A) Transcripts sequenced from 
a single amplicon, spanning from 5’ exon to the 3’ exon. B) Transcripts sequenced 
from two overlapping amplicons, bands shown that cover 5’ and 3’ ends C) Transcript 
sequenced from three overlapping amplicons, from 5’ to midsection to 3’ ends. D) 
Full-length transcript found with an alternative 3’UTR. Negative control = no 
template.  
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Figure 3: Degraded transcripts present in the bovine spermatozoa transcript profile. 
A) Transcripts with degradation, amplicons sorted by 5’ to 3’ end location. B) 
Transcripts degraded on the 5’ end, as well as having alternative 3’UTR. ATPase β 
and CHMP5 have only one band , but the band size and location of the poly(A) tail 
were different from the reference accession. Negative control = no template.  
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Figure 4: Oocyte and 2-Cell Embryo PCRs. All genes are arranged in order from left 
to right that the PCRs were performed. CO= cDNA oocyte, CE= cDNA 2-cell embryo, 
NT= No Template Control, NR= No RT Template Control, RO=RACE oocyte, 
RE=RACE 2-cell embryo, Sp= Spermatozoa cDNA from 9-bull pool.  
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Tables 
Table 1: Transcript identification methods. Lit=Literature Searches, Y Csome= Y 
chromosome located, GO=found in gene ontology translation category 
Gene FPKM 
Discovery 
Method Reference 
AKAP4 126.623 Lit 
Ostermeier et al., 2005; Iguchi et al., 2006; Miller et al., 2006; 
Boerke et al., 2007; Gilbert et al., 2007; Peddinti et al., 2008 
ATPase β 90.1644 High FPKM   
CCT8 17.9915 Lit Arangasamy et al., 2011 
CHMP5 2778.08 High FPKM   
CKS2 351.893 Lit Donovan et al., 2003; Smirnova et al., 2006 
CLGN 220.011 Lit Iguchi et al., 2006; Hecht et al., 2010; Evans, 2012 
CMYC 39.731 Lit 
Miller et al., 2006; Gilbert et al., 2007; Gur et al., 2008; Mayr et 
al., 2009; Johnson et al., 2011; Hamatani, 2012; Liu et al., 2012 
COX7A2 719.358 Lit 
Misirlioglu et al., 2006; Bermejo-Alvarez et al., 2010; Alshagga 
et al., 2011 
CRISP2 0.317044 Lit Arangasamy et al., 2011 
DDX3Y 10.9846 Lit, Y Csome 
Sekiguchi et al., 2004; Vong et al., 2006; Yao et al., 2010; Paria 
et al., 2011 
EEF1A1 431.873 GO   
EEF1G 116.059 GO   
GSTM3 2373.84 Lit 
Misirlioglu et al., 2006; Bermejo-Alvarez et al., 2010; Alshagga 
et al., 2011 
GTSF1 896.368 High FPKM   
H2AFZ 166.742 Lit 
Misirlioglu et al., 2006; Gilbert et al., 2007; Vigneault et al., 
2009; Bermejo-Alvarez et al., 2010 
HMGB4 6021.96 High FPKM   
PEBP1 29.3446 Lit Arangasamy et al., 2011 
PLCZ1 41.3639 Lit 
Miller et al., 2006; Swann et al., 2006; Boerke et al., 2007; 
Avendaño et al., 2009; Johnson et al., 2011; Fischer et al., 2012; 
Hamatani, 2012 
PRM1 20667.2 Lit 
Lassalle et al., 1999; Ostermeier et al., 2002; Miller et al., 2006; 
Gilbert et al., 2007; Lalancette et al., 2008; Avendaño et al., 
2009; Bissonnette et al., 2009; Carrell et al., 2010; Feugang et 
al., 2010; Hecht et al., 2010; Johnson et al., 2011; Ganguly et al., 
2012; Jenkins et al., 2012 
PSMA1 84.5454 High FPKM   
PSMA6 913.21 High FPKM   
SEC61G 309.446 High FPKM   
SPA17 927.374 High FPKM   
UBE2N 245.596 High FPKM   
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Table 2: Primers Used for PCR Amplification 
Gene 
Genbank 
ID Set Forward (5' → 3') Reverse (5' → 3') 
BP 
Covered 
Tota
l BP 
AKAP4 AF100170 1 AGGGGTCAGTGTGCCTTTTC TCGACCACCATCCCTACACT 385 - 998 2900 
    2 AACATGCACTGAGCCCTTCA TGGGCCATTTCAGAAGCGAT 481 - 931   
    3 TTTTACCAGACCAGTGGCCC GACACCCTGTATTTGCACAGTC 
231
0 - 
284
0   
    4 CTACCAAGACTCTCACGGGC ACACCCTGTATTTGCACAGTC 
236
3 - 
283
9   
    5 ACTTGGCACTGCCCACTTC TCCAGACGTAGGCTCTGAGG 41 - 618   
    6 GCTTCTGAAATGGCCCATGAT TCTTCACAGTTGAAGGGGCTC 915 - 
202
4   
    7 GAAAAGTGCGGAGGTAGCCA GACACCCTGTATTTGCACAGTC 
185
7 - 
284
0   
ATPase β BC102454 1 TGAGCGCACTCTGCTTGAG CAGGAACTCTCCGGTTGTCC 1 - 253 1525 
    2 GCACACACACCATGACGAAG ATCCAACGCTGACACTGGTT 156 - 442   
    3 AATGTGGGCCATGCTTCAGA GTTCAAAAGGCAGCAGAGGC 337 - 
121
0   
    4 
AGATAATAGTGGTCCATGTCCTTC
G CACTGAATTTCTTGCAGCTATGA 
115
1 - 
117
5   
CCT8 AF136609 1 CGAGATGGTGCCATTTCTACC TCTTTCTTCCCACTTGGAGGC 11 - 531 555 
CHMP5 BC103182 1 GAGTGTTTAGGTTTTCCTAGCGG GAAAGCCTCCTCCAAGCAA 1 - 869 1355 
    2 TGGCACGGTGGACAGCAGAG GAAAGCCTCCTCCAAGCAA 95 - 869   
    3 GGAGTCCTGGTGGATGAATTTGG AGCCTCCTCCAAGCAACGAGT 645 - 866   
CKS2 BC105331 1 GAGTCGAGTCGTTGCCTTCA GGACACCAAGTCTCCTCCAC 1 - 248 737 
    2 CTTCACCTGACCCGGACGTT 
AAAACACCTTACAGTAACCTACTT
G 16 - 528   
CLGN BC103401 1 TGGATTGAGCTGGGGGAGA ATTCACCACACCCAATCCGA 26 - 
118
1 2450 
    2 GGGCCCGCAAGACAGATAAT TCAAGCCAGCCATCAGGTTT 98 - 
105
6   
    3 ATGGATGGAGAATGGGAGGC 
GAAACTTTATTGCAATCAGCTCTG
T 
111
8 - 
238
5   
CMYC BC109848 1 GGCCGCTGTCACTATGGC TCCTCCTGAGGTGGTTCATACT 1 - 309 528 
    2 TGTCACTATGGCCCATTACAAA TGGTGAGGTGGTTCATACTGAG 7 - 306   
    3 ACTTAGGAGCTGCTACCCCA ACAGTTAACGTGTGATAGGTGA 165 - 463   
    4 CCACCTCAGGAGGAGAAACG ACAGTTAACGTGTGATAGGTGAAT 296 - 463   
COX7A2 DQ347636 1 AACTGGCTGTGGCTTCGTTT TGCTTTATTGGTGGCAGCTAA 1 - 204 206 
CRISP2 BC109478 1 CGGCCGCTCTGCAACAGAAG GTGCACTTGTTTGCCCACTT 20 - 437 1382 
    2 AGTCTCTCCACCTGCCAGTA TGCCTTCACACAGACAAGTCGCC 207 - 959   
    3 CACCTTGCGGCAGTTGCCCT TGCCTTCACACAGACAAGTCGCC 761 - 922   
DDX3Y GQ259590 1 TTGTTTCCGGTAGACCAACCTGTG AGCGCCCTTTGCTAGCTGTACT 15 - 234 2790 
    2 GGCCGTTCTAGGAGATTCAGTGG 
CAACTGAATCTGCTTTCCAGCCAA
G 
187
5 - 
212
0   
EEF1A1 AB099079 1 TCGTGTGGAGACTGGTGTTCT 
TTAAAGACTGGGGTGGCAGTATTG
G 4 - 634 636 
EEF1G AB098752 1 TCTTGCCCTGATTGAAGGCT ATGGCTGGTCCCTGTGG 89 - 443 443 
GSTM3 BC112491 1 GCGCTAAGGCACACAGGCGA 
GGGCCATCTTGTTGTTGACAGGCA
T 5 - 683 823 
    2 CCGCATGCTCCTGGAGTTCACG GTACAAGTCTGCCTCCTGCTC 94 - 728   
GTSF1 BC102713 1 GAGCACTTTGGATTTGGCTCC CACGTGCTCTCAGCCATAGT 1 - 326 666 
    2 AACTGGCAACTTGTCCCTTCA GCAACTCACAGACAGTTTATCTT 173 - 650   
H2AFZ BC109743 1 TGAGCGCAGTTTGAATCGC CCACCACCAGCAATTGTAGC 1 - 436 884 
    2 GTGGTGTCATTCCACACATCC 
ATGACCTTTATTGAGCTTATCCAC
C 433 - 863   
HMGB4 BC109790 1 ACAGAAAATTTCACCGCCAGC GACTCAGCTTGCTCGAACTCT 8 - 679 764 
PEBP1 BC102389 1 TTTAACCTGGGTGGGTGTCAGC CTCGTAAACCAGCCAGACATAGC 218 - 476 1476 
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    2 CCGATTATGTGGGCTCTGGG 
ACCAACTCCAGAACAGTTTTCTTT
T 409 - 
134
1   
    3 AAGAGATTGACTGTCTCCGCC ACAATATTCACCAACTCCAGAACA 
100
9 - 
135
0   
PLCZ1 AY646356 1 GCGTTTGGACCCAAAGGAAA AGCAAGGCATCCCCAAATGT 6 - 
108
9 2096 
    2 TTTGGGGATGCCTTGCTGTC AAGGCCACCATTTGACAACC 
107
3 - 
165
0   
    3 GGTCGGAATCCCACTCTTCA AAAAGGGAAGCGGGCTCAA 
134
8 - 
209
6   
PRM1 BC108207 1 GACAGCCCACAAATTCCACC GCAAGAGGGTCTTGAAGGCT 1 - 313 517 
    2 GCCAGATACCGATGCTCCTCA GTTAGCAGGCTCCTGTTCATGTC 98 - 364   
PSMA1 BC102216 1 TTCCACCCGCAGGTTTGAAG GCTGATTGAGATCGGGCTCC 3 - 554 1172 
    2 TTACGGGAAACCCTTCCTGC 
ACAGTTGTCTTTAAAACCACAAAG
A 634 - 
113
2   
PSMA6 BC110260 1 GAGGGACGGCTCTACCAAGT AGAGGCCGCATTTCAGCATT 118 - 464 984 
    2 CGAAATTCCCGTGGACATGC TGGCGTCACGGATTTGGTAA 384 - 838   
    3 
TGGGTTTAAAGCAACTGCAGCAGG
A ATCGAGGGGCCCCCAAAATGT 546 - 889   
SEC61G BC102186 1 GGCTCCTGTGCTACGTGTC TTTCTGCTCCATCAGCTTCTCA 5 - 339 523 
SPA17 BC103421 1 CCGGAACCATCGACTCCAGCTC 
TCTTGCTCCTTGAATGCATGGTTG
T 23 - 319 780 
    2 GGGGCTAAGGTTGATGACCGC GGCTAAGTGTCCCCGGAAGGC 267 - 464   
    3 TCAAGGAGCAAGAATCACCTG GTGGGGGTAAAGCCAGTCTC 307 - 551   
UBE2N BT030506 1 TGACAAGATGGCCGGGCTGC GTGAGGGCTGTGATGTCTGT 27 - 
106
8 2218 
    2 ATCATCGGTGTCTTGCCACA GAACAGCTTTGTGGTGGGGA 
150
3 - 
193
5   
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Table 3: Sequencing of bovine spermatozoa transcripts where base pairs matched the 
predicted transcript using primers in Table 1. Y= Yes, N= No, n/a = no poly(A) 
present in genbank accession, * = Poly A tail is present but not where the original 
accession number indicates it.  A) full-length transcripts B) degraded transcripts 
A) 
Gene 
Genbank 
ID 
Total 
BP 
% 
Sequenced BP sequenced 
Poly A 
Tail 
CCT8 AF136609 554 100 1 - 536 Y 
COX7A2 BC102664 205 100 1 - 205 N 
CRISP2 BC109478 1382 100 1 - 1382 Y 
EEF1A1 AB099079 636 100 1 - 636 Y 
EEF1G AB098752 443 100 1 - 443 Y 
GSTM3 BC112491 823 100 1 - 823 Y 
PLCZ1 AY646356 2096 97 68 - 2096 Y 
PRM1 BC108207 517 100 1 - 517 Y 
PSMA1 BC102216 1172 100 1 - 1172 Y 
HMGB4 BC109790 764 94 45 - 764 Y 
GTSF1 BC102713 666 94 43 - 666 Y 
CKS2 BC105331 737 93 49 - 737 Y 
H2AFZ BC109743 884 93 1 - 437 Y 
        497 - 884   
PSMA6 BC110260 984 90 1 - 890 Y* 
SEC61G BC102186 523 89 57 - 523   
CMYC BC109848 528 89 1 - 461 N 
B) 
Gene 
Genbank 
ID 
Total 
BP 
% 
Sequenced BP sequenced 
Poly A 
Tail 
SPA17 BC103421 780 60 1 - 320 N 
        370 - 514   
AKAP4 AF100170 2900 50 440 - 1038 Y 
        2056 - 2900   
PEBP1 BC102389 1476 50 370 - 684 N 
        1060 - 1476   
ATPase 
β BC102454 1525 31 1055 - 1525 Y* 
CLGN BC103401 2450 31 117 - 327 Y 
        1017 - 1181   
        1656 - 1684   
        2105 - 2450   
CHMP5 BC103182 1355 22 66 - 269 Y* 
        647 - 740   
UBE2N BT030506 2218 21 160 - 442 N 
        878 - 1067   
DDX3Y GQ259590 2790 12 9 - 87 Y* 
        1948 - 2203   
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Table 4: Transcript presence in testis, sperm, oocyte and embryos from published 
microarray studies.   Y=transcript present, N= transcript absent, M=results 
inconclusive. Oocyte & Embryo microarray data are from Kocabas et al. 2006. Testis 
and spermatozoa microarray data are from Chalmel et al., 2007.  
 
Gene 
Genbank 
ID Testis Sperm Oocyte Embryo 
AKAP4 AF100170 Y Y N N 
ATPase 
β BC102454 Y Y Y N 
CCT8 AF136609 Y Y Y Y 
CHMP5 BC103182 Y Y Y N 
CKS2 BC105331 Y M Y Y 
CLGN BC103401 Y M N N 
CMYC BC109848 Y N N Y 
CRISP2 BC109478 Y Y N Y 
DDX3Y GQ259590 Y Y N Y 
EEF1A1 AB099079 Y Y Y N 
EEF1G AB098752 Y Y Y Y 
GSTM3 BC112491 Y Y Y N 
GTSF1 BC102713 Y Y Y N 
H2AFZ BC109743 Y Y M Y 
HMGB4 BC109790 Y Y N Y 
PEBP1 BC102389 Y Y Y Y 
PLCZ1 AY646356 Y Y N N 
PRM1 BC108207 Y Y N N 
PSMA1 BC102216 Y Y Y Y 
PSMA6 BC110260 Y Y M Y 
SEC61G BC102186 Y M Y Y 
SPA17 BC103421 Y Y N N 
UBE2N BT030506 Y Y Y M 
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APPENDICES 
 
APPENDIX I: PROTOCOLS 
A) Testis RNA Isolations 
B) Spermatozoa RNA Isolations 
C) Oocyte & Embryo RNA Isolations 
D) Reverse Transcription 
E) Standard Polymerase Chain Reaction 
F) cDNA Amplification 
G) Rapid Amplification of cDNA Ends Polymerase Chain Reaction 
H) Primer Dilution from IDT 
I) Gel Extraction Protocol 
J) Sequencing 
K) RNA-Sequencing Protocols 
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A) Testis RNA Isolation Protocol 
Tips & Techniques: 
• Turn on microfuge and let cool to 4°C (20 minutes) 
• Set up a ribonuclease free environment 
o Preparation: RNase/DNase free microfuge tubes, tips etc. 
• KEEP SAMPLE ON ICE – except where noted 
 
Protocol 
1. Add 200 ul of TRI REAGENT to 100 mg tissue and homogenize with RNase-free 
blue pestle on ice. Add additional 800 ul of TRI REAGENT and mix.  
2. Let sit at room temperature for 5 min (Can store in –80°C at this point) 
3. Add 0.2 ml of chloroform per 1 ml of TRI REAGENT  
4. Shake vigorously for 15 sec and let stand for 2-15 min 
5. Centrifuge at 12,000 x g for 15 min at 4°C 
6. Remove clear aqueous phase (top layer) and transfer to a new tube  
7. Add 0.5 ml isopropanol/ml TRI REAGENT and let sit for 5-10 min at RT 
8. Centrifuge at 12,000 g for 10 min at 4°C 
9. Remove supernatant and wash the RNA pellet by adding 1 ml (minimum) of 75% 
ethanol (prepared with DEPC-treated water) per 1 ml of TRI REAGENT used in 
preparation.   
• (Samples can be stored in ethanol at 4°C for 1 week and up to 1 year at -
20°C). 
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10. Vortex the sample and centrifuge at 7,500 for 5 min at 4°C 
11. Briefly dry the RNA pellet for 5-10 min by air-drying on ice. 
12. Add 10-50 ul of DEPC-water to RNA pellet.  Mix at 55-60°C for 10-15 min. 
 
RNA storage 
Aqueous aliquots: After isolation, determine concentration using Nano drop in 10 
mM Tris, pH 7.0. Freeze in 5 ug, 10 ug  or 15 ug aliquots in DEPC-water. Store at -
80°C  
Ethanol aliquots:  most stable. Precipitate by adding 1/10th volume 1M sodium 
acetate, pH 4.8 and 2.5 volumes of 95% ethanol. Store at -20°C. To retrieve: 
centrifuge at 7,5000 for 5 min at 4°C. Remove 95% ethanol from pellet and add 1 ml 
of 75% ethanol. Centrifuge at 7,5000 for 5 min at 4°C.  Remove ALL ethanol, briefly 
air dry and re-suspend in DEPC-H20. 
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B) Spermatozoa RNA Isolations 
TRIzol Isolation with adaptations from Stallion Paper 
1. Wash spermatozoa straws in 4 mL 1x PBS twice at 800x g for 10 minutes. 
• PBS at Room temp, water bath for spermatozoa straws at 37O 
2. Add 1 mL TRIzol reagent to spermatozoa pellet + 3 µL Glycogen. 
3. Lyse sample with 26 ga, 6cc needle 20 times and incubate for 30 minutes at 
room temp. 
4. Add 200 µL chloroform per 1 mL TRIzol reagent to sample. 
• Shake for 20 seconds then let sit at room temperature for 10 minutes. 
5. Centrifuge at 12,000x g for 15 minutes at 4O C. 
6. Remove clear aqueous layer at top (contains RNA) and put in new tube. 
7. Add 500 µL ice cold isoproanol and let sit for 10 minutes on ice. 
• Keep on ice for the remainder of isolation protocol. 
8. Centrifuge at 12,000x g for 10 minutes at 4O C.  
9. Remove and discard supernatant and add 1 mL 75% ethanol to pellet. 
• Vortex briefly, then centrifuge at 12,000x g for 5 minutes at 4O C. 
10. Remove supernatant and air dry pellet on ice for 5 - 10 minutes. 
• After 5 minutes on ice, remove any accumulated supernatant again. 
11. Heat Tris for elution to 65O C and add 60 µL to pellet. 
• Vortex until RNA pellet is dissolved in solution. 
12. Nanodrop and store sample at -80O C. 
Total time expected: ~3 hours  
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C) Oocyte & Embryo RNA Isolations  
 (with PicoPure RNA isolation Kit) 
**Clean bench well with RNase out/Zap & wipe everything with 70% ethanol** 
** No need to dump waste between samples!** 
1. Aliquot 20 µl of Extraction buffer (XB) into a 1.5 ml RNase-free tube 
2. Collect oocytes/embryos into the extraction buffer 
3. Parafilm tube and incubate in 42°C waterbath for 30 minutes (do not spin).  
• Stopping point: freeze on dry ice. (Our shipped samples are here)  
4. Add 250 µl of Conditioning buffer (CB) onto the purification column.  
5. Incubate at room temperature for 5 minutes.  
6. Centrifuge column at 16.0 rcf for 1 minute  
7. Add 20 µl of 70% ethanol into the cell extract from step number 3.  
8. Mix well by pipetting (do not centrifuge).  
9. Add the mixture onto the pre-conditioned column.  
10. Centrifuge for 2 minutes at .1 rcf  
11. Centrifuge for 30 seconds at 16.0 rcf 
12. Add 100 µl of Wash Buffer 1 (W1)  
13. Centrifuge for 1 minute at 8.0 rcf 
14. Add 100 µl of Wash Buffer 2 (W2)  
15. Centrifuge for 1 minute at 8.0 rcf  
16. Add 100 µl of Wash Buffer 2 (W2)  
17. Centrifuge for 3 minutes at 16.0 rcf 
18.  Add 20 µl of Elution buffer (EB) to the column.  
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19. Incubate for 1 minutes at room temperature  
20. Centrifuge for 1 minute at 1.0 rcf 
21. Centrifuge for 1 minute at 16.0 rcf  
22. Nanodrop and store in -80°C 
** Do samples separately! Get better results if samples are done separate and **     
then combined and vacuumed. 
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D) Reverse Transcription 
Superscript TM III 
RT Reaction 
1. Add the following to the 10ul of ligated RNA (want [ ] 2ug + xul dH20 = 10ul 
total) 
• GeneRacer OligoDT Primers 1ul 
• dNTP Mix   1ul 
• Sterile dH20   1ul 
2. Incubate at 65°c for 5 min to remove and RNA secondary structure 
3. Chill on ice for at least 1 min and centrifuge briefly 
4. Add the following reagents to the 13ul ligated RNA and primer mixture: 
• 5X First Strand Buffer  4ul 
• 0.1 M DTT     1ul 
• RNaseOutTM (40U/ul)  1ul 
• SuperScriptTM III RT (200U/ul) 1ul 
• Total     20ul 
5. Mix well by pipetting up and down gently 
6. Centrifuge briefly and incubate at 50°c for 45 min 
7. Inactivate the RT reaction at 70°c for 15 min 
8. Chill on ice for 2 min and centrifuge briefly 
9. Add 1ul of RNaseH (2U) to the reaction mix 
10. Incubate at 37°c for 20 min 
Centrifuge briefly and use immediately for amplification or store at -20°c
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E) Standard Polymerase Chain Reaction 
• Wear gloves 
• Make aliquots of kit components for own use – except for Taq 
• Make sure to vortex MgCl2 well 
• Make master mix for number of samples + 1 
Sample Types: 
1.) cDNA from RT reaction 
2.) RT negative control: no enzyme  
3.) RT negative control: no template RNA 
4.) PCR negative control: no template RT added 
PCR Reaction Master Mix: 
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• Mix well and centrifuge 
• Make sure no bubbles are present before PCR reaction 
PCR conditions: 
• 1 cycle: 94°C for 3 min 
• 35 cycles: 94°C for 30 sec, ____°C for 30 sec, 72°C for 30 sec 
• 1 cycle: 72°C for 10 min 
• Hold at 4°C 
Store at -20°C until analysis 
MgCl2 Gradient Option: 
Reagents x1 x2 x3 x4 x5 x6 
Std Taq Buffer 5 10 15 20 25 30 
Forward GSP 4 8 12 16 20 24 
Reverse GSP 4 8 12 16 20 24 
MgCl2 1 2 3 4 5 6 
dNTPs 1 2 3 4 5 6 
Taq 0.5 1 1.5 2 2.5 3 
Water 33.5 32.5 31.5 30.5 29.5 28.5 
Total Per Tube 49 49 49 49 49 49 
Template Per Tube 1 1 1 1 1 1 
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F) cDNA Amplification 
First-strand cDNA synthesis 
1. For each sample and Control Mouse Liver Total RNA, combine the following 
reagents in separate 0.5 ml reaction tubes:   
 
 
 
 
*For the control synthesis, add 10 ng of Control Mouse Liver Total RNA.  
2. Mix contents and spin the tubes briefly in a microcentrifuge. 
3. Incubate the tubes at 72°C in a hot-lid thermal cycler for 3 min, and then cool the 
tubes to 42°C. 
4. Prepare a Master Mix for all reaction tubes at room temperature by combining the 
following reagents in the order shown:  
 
 
 
 
 
* Add to the master mix just prior to use. Mix well by vortexing & spin down. 
5. Aliquot 49 µl of the Master Mix into each reaction tube. Mix the contents of the 
tubes by gently pipetting, and spin the tubes briefly to collect the contents at the 
bottom. 
1–50 µl  RNA (1-1,000 ng of total RNA)* 
7 µl   3’ SMART CDS Primer II A (12 µM) 
x µl   Deionized H2O    
57 µl   Total Volume 
 
20 µl  5X First-Strand Buffer  
2 µl  DTT (100 mM) 
10 µl  dNTP Mix (10 mM) 
7 µl  SMARTer II A Oligonucleotide (12 µM) 
5 µl  RNase Inhibitor 
5 µl  SMARTScribe™ Reverse Transcriptase (100 
U)* 
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6. Incubate the tubes at 42°C for 1 hour. 
NOTE: If your downstream application requires long transcripts, extend 
incubation time to 90 min. 
7. Terminate the reaction by heating the tubes at 70°C for 10 min. 
8. If necessary, cDNA samples can be stored at –20°C (for up to three months) until 
you are ready to proceed with spin-column purification. 
 
Column purification of cDNA using NucleoSpin gel and PCR clean-up 
1. Add 350 µl of Buffer NT to each cDNA synthesis reaction; mix well by pipetting. 
2. Place a NucleoSpin Gel and PCR Clean-Up Column into a 2 ml collection tube. 
Pipette the sample into the column. Centrifuge at 8,000 rpm for 1 min. Discard the 
flowthrough. 
3. Return the column to the collection tube. Add 600 µl of Wash Buffer NT3 to the 
column. Centrifuge at 14,000 rpm for 1 min. Discard the flowthrough. 
4. Return the column to the collection tube. Add 250 µl of Wash Buffer NT3 to the 
column. Centrifuge at 14,000 rpm for 1 min. Discard the flowthrough. 
5. Place the column back into the collection tube. Centrifuge at 14,000 rpm for 2 min 
to remove any residual Wash Buffer NT3. 
6. Transfer the NucleoSpin Columns into a fresh 1.5 ml microcentrifuge tube. Add 
50 µl of sterile Milli-Q H2O to the column. Allow the column to stand for 2 min 
with the caps open. 
7. Close the tube and centrifuge at 14,000 rpm for 1 min to elute the sample. 
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8. Repeat elution with 35 µl of sterile Milli-Q H2O in the same 1.5 ml 
microcentrifuge tube. The recovered elution volume should be 80–85 µl per 
sample. If necessary, add sterile Milli-Q H2O to bring the total volume up to 80 µl. 
9. For PCR-Select cDNA subtraction, proceed with the protocols provided in 
Appendix A of this User Manual. For all other applications, proceed with Section 
D. Samples can be stored at –20°C (for up to three months) until you are ready to 
proceed with cDNA amplification by LD PCR. 
 
cDNA amplification by LD PCR 
1. Preheat the PCR thermal cycler to 95°C. 
2. For each reaction, aliquot the appropriate volume (see T able II) of each diluted 
first-strand cDNA into a labeled 0.5 ml reaction tube. If necessary, add deionized 
H2O to adjust the volume to 80 µl. 
 
Table II: Guidelines for Setting Up PCR Reactions 
Total RNA 
(ng) 
Volume of Diluted 
ss cDNA for PCR 
(uL) 
Volume of H20 
(uL) 
Typical Optimal No. of 
PCR Cycles* 
1000 2.5 77.5 18-20 
250 10 70 18-20 
100 25 55 18-20 
50 40 40 18-20 
20 80 none 19-21 
5 80 none 21-23 
1 80 none 24-27 
 
3. Prepare a Master Mix for all reactions, plus one additional reaction. Combine the 
following reagents in the order 
4 µl  Deionized H2O 
10 µl  10X Advantage 2 PCR Buffer 
2 µl  50X dNTP Mix (10 mM) 
2 µl  5’ PCR Primer II A (12 µM) 
2 µl  50X Advantage 2 Polymerase 
Mix 
20 µl  Total Volume per reaction 
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shown: 
 
 
 
 
 
 
 
4. Mix well by vortexing and spin the tube briefly in a microcentrifuge. 
5. Aliquot 20 µl of the PCR Master Mix into each tube from Step 2. 
6. Cap the tube, and place it in the preheated thermal cycler. If you are NOT using a 
hot-lid thermal cycler, overlay the reaction mixture with two drops of mineral oil. 
 
Table III: Cycling Guidelines Based on Starting Material 
No. of Cells  
(e.g. HeLa) Typical Yield of Total RNA (ng) 
Typical No. of  
PCR Cycles 
~10 0.15 27 
~100 1.5 24 
~1,000 15 20 
~10,000 150* 18 
 
7. Commence thermal cycling using the following program: 
• 95°C 1 min 
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• X cycles at: 95°C 15 sec 
65°C 30 sec 
68°C 3 min 
a) Consult Tables II & III for guidelines. Subject all tubes to 15 cycles. Then, 
divide the PCR reaction mix between the “Experimental” and “Optimization” 
tubes, using the Optimization tube for each reaction to determine the optimal 
number of PCR cycles, as described in Step 8. 
b) For applications requiring longer cDNA transcripts, increase to 6 min. 
8. Subject each reaction tube to 15 cycles, then pause the program. Transfer 30 µl 
from each tube to a second reaction tube labeled “Optimization”. Store the 
“Experimental” tubes at 4°C. Using the Tester PCR tube, determine the optimal 
number of PCR cycles (see Figure 3): 
a) Transfer 5 µl from the 15 cycle PCR reaction tube to a clean microcentrifuge 
tube (for agarose/EtBr gel analysis). 
b)  Return the Optimization tubes to the thermal cycler. Run three additional 
cycles (for a total of 18) with the remaining 25 µl of PCR mixture. 
c) Transfer 5 µl from the 18 cycle PCR reaction tube to a clean microcentrifuge 
tube (for agarose/EtBr gel analysis). 
d) Run three additional cycles (for a total of 21) with the remaining 20 µl of PCR 
mixture. 
e) Transfer 5 µl from the 21 cycle PCR to a clean microcentrifuge tube (for 
agarose/EtBr gel analysis). 
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f) Run three additional cycles (for a total of 24) with the remaining 15 µl of PCR 
mixture. 
g) Transfer 5 µl from the 24 cycle PCR to a clean microcentrifuge tube (for 
agarose/EtBr gel analysis). 
h) Run three additional cycles (for a total of 27) with the remaining 10 µl of PCR 
mixture. 
i) Transfer 5 µl from the 27 cycle PCR to a clean microcentrifuge tube (for 
agarose/EtBr gel analysis). 
j) Run three additional cycles (for a total of 30) with the remaining 5 µl of PCR 
mixture. 
9. Electrophorese each 5 µl aliquot of the PCR reaction alongside 0.1 µg of 1 kb 
DNA size markers on a 1.2% agarose/EtBr gel in 1X TAE buffer. Determine the 
optimal number of cycles required for each experimental and control sample (see 
Figure 4, Section VI). 
10. Retrieve the 15 cycle Experimental PCR tubes from 4°C, return them to the 
thermal cycler, and subject them to additional cycles, if necessary, until you reach 
the optimal number. 
11. When the cycling 11. is completed, analyze a 5 µl sample of each PCR product 
alongside 0.1 µg of 1 kb DNA size markers on a 1.2% agarose/EtBr gel in 1X 
TAE buffer. Compare your results to Figure 4 to confirm that your reactions were 
successful. 
12. Add 2 µl of 0.5 M EDTA to each tube to terminate the reaction. 
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Column purification of PCR products using NucleoSpin gel and PCR clean-up 
1. Add 300 µl Binding NT Buffer to each 70 µl PCR reaction. Mix well by 
pipetting. 
2. Place a NucleoSpin column into a 2 ml Collection Tube, and pipette the 
sample onto the filter. Centrifuge at 8,000 rpm for 1 min. Discard the 
Collection Tube and flowthrough. 
3. Insert the NucleoSpin column into a fresh 2 ml Collection Tube. Add 600 µl 
Wash Buffer NT3 to the column. Centrifuge at 14,000 rpm for 1 min. Discard 
the flowthrough. 
4. Return the column to the Collection Tube. Add 250 µl Wash Buffer NT3 to the 
column. Centrifuge at 14,000 rpm for 1 min. Discard the flowthrough. 
5. Discard the flowthrough and spin again at 14,000 rpm for 1 min to remove the 
final traces of ethanol to dry the filter. 
6. Transfer the NucleoSpin column to a clean 1.5 ml microcentrifuge tube. 
Pipette 50 µl Elution Buffer NE directly onto the filter, being careful not to 
touch the surface of the filter with the tip of the pipette. Allow the filter to soak 
for 2 min with the lid open. 
7. Close the tube and centrifuge at 14,000 rpm for 1 min to elute PCR product. 
Save the column. 
8. Determine the yield of each PCR product by measuring the A260. For each 
reaction, we usually obtain 1–2 µg of SMARTer cDNA after purification. 
9. If no product is detected, perform elution (Steps 6 and 7) a second time, using 
a fresh 1.5 ml microcentrifuge tube. 
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G) Rapid Amplification of cDNA Ends Polymerase Chain Reaction 
Use 1-5 ug Total RNA 
 
Dephosphorylating RNA 
~ 1 Hour 
1. Set up on ice the following 10 µl dephosphorylation reaction in a 1.5 ml sterile 
microcentrifuge tube using the reagents in the kit. Use 1-5 µg total RNA or 50-
250 ng mRNA. 
 
  
 
2. Mix gently by pipetting and vortex briefly. Centrifuge to collect fluid. 
 
3. Incubate at 50°C for 1 hour. After incubation, centrifuge briefly and place on 
ice. 
Precipitating RNA 
~45 minutes 
1. To precipitate RNA, add 90 µl DEPC water and 100 µl phenol:chloroform and 
vortex vigorously for 30 seconds. 
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2. Centrifuge at maximum speed for 5 minutes at room temperature. 
3. Transfer aqueous (top) phase to a new microcentrifuge tube (~100 µl). 
4. Add 2 µl 10 mg/ml mussel glycogen, 10 µl 3 M sodium acetate, pH 5.2, and 
mix well. Add 220 µl 95% ethanol and vortex briefly. 
5. Freeze on dry ice for 10 minutes. You may proceed to the next step or store at -
20°C overnight. 
• Note: Do not store the RNA in DEPC water. Store RNA in ethanol at -
20°C. 
6. To pellet RNA, centrifuge at maximum speed in a microcentrifuge for 20 
minutes at +4°C. 
7. Note the position of the pellet and remove the supernatant by pipet. Be careful 
not to disturb pellet. 
8. Add 500 µl 70% ethanol, invert several times, and vortex briefly. 
9. Centrifuge at maximum speed in a microcentrifuge for 2 minutes at +4°C. 
10. Note the position of the pellet and carefully remove the ethanol using a pipet. 
Centrifuge again to collect remaining ethanol. 
11. Carefully remove the remaining ethanol by pipet and air-dry the pellet for 1-2 
minutes at room temperature. 
12. Resuspend the pellet in 7 µl DEPC water. If you want to check the stability of 
RNA after the CIP reaction, resuspend the pellet in 8 µl DEPC water and 
analyze 1 µl by agarose gel electrophoresis. Proceed to Removing the mRNA 
Cap Structure. 
 
125 
 
Decapping Reaction 
~1 hour 
1. Set up on ice the 10 µl decapping reaction in a 1.5 ml sterile microcentrifuge 
tube using the reagents in the kit. 
• Dephosphorylated RNA  7 µl 
• 10X TAP Buffer  1 µl 
• RNaseOut™ (40 U/µl)  1 µl 
• TAP (0.5 U/µl)   1 µl   
• Total Volume   10 µl 
2. Mix gently by pipetting and vortex briefly. Centrifuge briefly to collect fluid. 
3. Incubate at 37°C for 1 hour. 
4. After incubation, centrifuge briefly and place on ice. 
5.  
Precipitating RNA 
~45 Minutes 
1. To precipitate RNA, add 90 µl DEPC water and 100 µl phenol:chloroform and 
vortex vigorously for 30 seconds. 
2. Centrifuge at maximum speed in a microcentrifuge for 5 minutes at room 
temperature. 
3. Transfer aqueous (top) phase to a new microcentrifuge tube (~100 µl). 
4. Add 2 µl 10 mg/ml mussel glycogen, 10 µl 3 M sodium acetate, pH 5.2, and 
mix well. Add 220 µl 95% ethanol and vortex briefly. 
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5. Freeze on dry ice for 10 minutes. You may proceed to the next step or store at -
20°C overnight. 
• Note: Do not store the RNA in DEPC water. Store RNA in ethanol at -
20°C. 
6. To pellet RNA, centrifuge at maximum speed in a microcentrifuge for 20 
minutes at +4°C. 
7. Note the position of the pellet and remove the supernatant by pipet. Be careful 
not to disturb pellet. 
8. Add 500 µl 70% ethanol, invert several times, and vortex briefly. 
9. Centrifuge at maximum speed in a microcentrifuge for 2 minutes at +4°C. 
10. Note the position of the pellet and carefully remove the ethanol using a pipet. 
Centrifuge again to collect remaining ethanol. 
11. Carefully remove the remaining ethanol by pipet and air-dry the pellet for 1-2 
minutes at room temperature. 
12. Resuspend the pellet in 7 µl DEPC water. If you want to check the stability of 
RNA after the CIP reaction, resuspend the pellet in 8 µl DEPC water and 
analyze 1 µl by agarose gel electrophoresis. Proceed directly to Ligating the 
RNA Oligo to Decapped mRNA.  
13.  
Ligation Reaction 
~ 1 hour 10 minutes 
1. Add 7 µl of dephosphorylated, decapped RNA to the tube containing the pre-
aliquoted, lyophilized GeneRacer™ RNA Oligo (0.25 µg). Pipet up and down 
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several times to mix and resuspend RNA Oligo. Centrifuge briefly to collect 
the fluid in the bottom of the tube. 
2. Incubate at 65°C for 5 minutes to relax the RNA secondary structure.  
• Note: After the incubation, the total volume of this solution may 
decrease by 1 µl due to evaporation. 
3. Place on ice to chill (~2 minutes) and centrifuge briefly. 
4. Add the following reagents to the tube, mix gently by pipetting, and centrifuge 
briefly. 
• 10X Ligase Buffer   1 µl 
• 10 mM ATP    1 µl 
• RNaseOut™ (40 U/µl)  1 µl 
• T4 RNA ligase (5 U/µl)  1 µl  
• Total Volume    10 µl 
5. Incubate at 37°C for 1 hour. Centrifuge briefly and place on ice. Precipitate the 
RNA. 
 
Precipitating RNA 
~45 minutes 
1. To precipitate RNA, add 90 µl DEPC water and 100 µl phenol:chloroform and 
vortex vigorously for 30 seconds. 
2. Centrifuge at maximum speed in a microcentrifuge for 5 minutes at room 
temperature. 
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3. Transfer aqueous (top) phase to a new microcentrifuge tube (~100 µl). 
4. Add 2 µl 10 mg/ml mussel glycogen, 10 µl 3 M sodium acetate, pH 5.2, and 
mix well. Add 220 µl 95% ethanol and vortex briefly. 
5. Freeze on dry ice for 10 minutes. You may proceed to the next step or store at -
20°C overnight. 
• Note: Do not store the RNA in DEPC water. Store RNA in ethanol at -
20°C. 
6. To pellet RNA, centrifuge at maximum speed in a microcentrifuge for 20 
minutes at +4°C. 
7. Note the position of the pellet and remove the supernatant by pipet. Be careful 
not to disturb pellet. 
8. Add 500 µl 70% ethanol, invert several times, and vortex briefly. 
9. Centrifuge at maximum speed in a microcentrifuge for 2 minutes at +4°C. 
10. Note the position of the pellet and carefully remove the ethanol using a pipet. 
Centrifuge again to collect remaining ethanol. 
11. Carefully remove the remaining ethanol by pipet and air-dry the pellet for 1-2 
minutes at room temperature. 
12. Resuspend the pellet in 7 µl DEPC water. If you want to check the stability of 
RNA after the CIP reaction, resuspend the pellet in 8 µl DEPC water and 
analyze 1 µl by agarose gel electrophoresis. Proceed to Reverse Transcribing 
mRNA. 
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Reverse Transcribing mRNA (Superscript III RT Reaction) 
~ 2 Hours 
1. Add the following to the 10 µl of ligated RNA from Step 12: 
• Primers    1 µl 
• dNTP Mix   1 µl 
• Sterile, distilled water  1 µl 
2. Incubate at 65°C for 5 minutes to remove any RNA secondary structure. 
3. Chill on ice for at least 1 minute and centrifuge briefly. 
4. Add the following reagents to the 13-µl ligated RNA and primer mixture: 
• 5X First Strand Buffer   4 µl 
• 0.1 M DTT    1 µl 
• RNaseOut™ (40 U/µl)   1 µl 
• SuperScript™ III RT (200 U/µl)  1 µl   
• Total Volume    20 µl 
5. Mix well by pipetting gently up and down. 
• Note: If you are using random primers, incubate the reaction mix at 25°C 
for 5 minutes prior to Step 6 to allow efficient binding of the random 
primers to the template. 
6. Centrifuge briefly and incubate at 50°C for 30-60 minutes. If you are using 
gene-specific primers, increase the reaction temperature to 55°C. 
7. Inactivate the RT reaction at 70°C for 15 minutes. Chill on ice for 2 minutes 
and centrifuge briefly at maximum speed in a microcentrifuge. 
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8. Add 1 µl of RNase H (2 U) to the reaction mix. 
9. Incubate at 37°C for 20 minutes. 
10. Centrifuge briefly and use immediately for amplification or store at -20°C. 
You may use up to 2 µl of the RT reaction in each PCR reaction. 
Nested PCRs with GSPs 
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H) Primer Dilution from IDT 
To make freezer stock:  
1.  Spin down tubes 
2.  Add dH20 water to 50 µM (50 pmoles/ul) 
• Divide amount of oligo in nMoles by 50 µM 
• Typical volumes range from 300- 800 µl 
3. Vortex well 
4. Store at -20°C  
5. Note primer location on Primer Inventory Sheet 
 
To make 10 µM PCR Stock:  
100 µl  of 50 µM primer  
400 µl  of dH20 
Store at -20°C 
 
To make 2.5 µM working PCR stock 
125 µl  of 10 µM primer  
375 µl  of dH20 
Store at -20°C 
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I) Gel Extraction Protocol 
1.) Excise the DNA fragment from the agarose gel with a clean, sharp scalpel.  
Minimize the size of the gel slice by removing extra agarose. 
2.) Weigh the gel slice in a colorless tube.  Add 3 volumes of Buffer QG to 1 volume 
of gel (100mg ~100 ul). 
3.) Incubate at 50°C for 10 min (or until the gel slice has completely dissolved).  
Vortex the tube every 2-3 min during the incubation to mix. 
4.) After the gel slice has dissolved completely, check that the color of the mixture is 
yellow. 
5.) Add 1 gel volume of isopropanol to the sample and mix. 
6.) Place a QIAquick spin column in a provided 2 ml collection tube (already done). 
7.) To bind DNA, apply the sample to the QIAquick column, and centrifuge for 1 min.  
The maximum volume of the column reservoir is 800 ul.  For sample volumes of 
more than 800 ul, simply load and spin again. 
8.) Discard flow-through and place QIAquick column back in the same collection 
tube. 
9.) Add 500ul of Buffer QG to QIAquick column and centrifuge for 1 min.  This step 
will remove all traces of agarose. 
10.) To wash, add 750ul of Buffer PE to QIAquick column and centrifuge for 1 
min. 
11.) Discard flow-through and centrifuge the QIAquick column for an extra 1 min   
       at ≥10,000 X g (~13,000 rpm). 
12.) Place a QIAquick column into a clean 1.5 ml microcentrifuge tube. 
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13.) To elute DNA, add 50 ul autoclaved H2O to the center of the QIAquick  
       membrane and centrifuge the column for 1 min at maximum speed.   
14.) Reapply the flow-through and centrifuge again for 1 min.  
15.) Check concentration of samples by nanodrop or running a 2% agarose gel 
**Store samples at -20°C** 
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J) Sequencing 
Following URI GSC Instructions: 
Target amounts for dsDNA templates: 
• PCR products: 2.5 ng DNA per 100 bases per reaction 
• Plasmids: 300-500 ng DNA per reaction 
Primer amount: 
• Use one primer only; either forward or reverse, but not both! 
• 5 pmol per reaction (Note: 5 pmol = 2.0 µl of a 2.5 µM stock) 
Single sample volume: 
• 12 µl per reaction; add template plus one primer in the amounts above to MB 
grade water. 
To facilitate pipetting, submit your sample in duplicate with a total volume of 24 µl. 
Submit your template and primer combined in a 0.5 or 1.5ml tube. DO NOT submit 
samples in individual 0.2 ml (200µl) tubes. When submitting 16 or more samples, 
please submit them in 8-tube strip-tube(s) (capped) or a 96-well plate (capped or 
sealed). 
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Sample Analysis:  
Sequencing on the ABI 3130xl genetic analyzer is routinely conducted using POP7 
polymer, a 50 cm. 16-capillary array and the KB Basecaller software. These 
conditions normally produce high quality sequence that extends to 800-1,000 bases.  
PCR products less than 900 bp in length will be analyzed in the 3130xl using an 
analytical protocol that looks for the end of the raw data. Please identify your PCR 
product and its size on the Submission Form so this protocol may be specified during 
instrument setup.  
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K)  RNA-Sequencing Protocols 
Protocol for Gene Ontology (GO) Analysis 
• Logon to the DAVID database ( http://david.abcc.ncifcrf.gov/) 
• Select “Start Analysis” from top menu 
• Copy transcript list of interest into the “Paste a list” box 
 Use Genbank IDs from RNA-Seq study 
o For the “Select Identifier” box, choose appropriate type of sample 
accession submitted 
 Use “GENBANK_ACCESSION” for RNA-Seq study 
o List Type: “Gene List” 
o Hit “Submit List” 
• Select species “Bos taurus” 
• On right, choose “Functional Annotation Tool” 
• Click “Gene_Ontology” 
o Should automatically have “GOTERM_BP_FAT,” 
“GOTERM_CC_FAT ,” “GOTERM_MF_FAT ” selected 
• Click “Chart” next to each checked box 
• Click “Download File” in top right corner 
• Copy entire window into a .txt file and save 
• Open the .txt file with excel, which should automatically insert tab delimiters 
o Can sort file according to target information 
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Getting official gene symbols & long names from accession numbers 
• Logon to the DAVID database ( http://david.abcc.ncifcrf.gov/) 
• Select “Start Analysis” from top menu 
• Copy transcript list of interest into the “Paste a list” box 
 Use Genbank IDs from RNA-Seq study 
o For the “Select Identifier” box, choose appropriate type of sample 
accession submitted 
 Use “GENBANK_ACCESSION” for RNA-Seq study 
o List Type: “Gene List” 
o Hit “Submit List” 
• On top menu, click “Shortcut to DAVID Tools” 
• Click “Gene ID Conversion” 
• Select “OFFICIAL_GENE_SYMBOL” from drop down menu 
• Click “Submit to Conversion Tool” 
• Click “Download File” in top right corner 
• Copy entire window into a .txt file and save 
• Open the .txt file with excel, which should automatically insert tab delimiters 
o Can sort file according to target information 
Pairing gene symbols & long names with known accessions 
• Open file that you’re annotating these names onto, referred to here as “FILE 1” 
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• Open file with accessions/official gene IDs/long names in it, referred to here as 
“FILE 2” 
 
• Temporarily copy all the information from “FILE 2” into blank columns to the 
right of the data in “FILE 1” 
• In “FILE 1,” add two additional columns to the right of the Genbank ID 
column 
o Title one “Gene ID” and the other “Long Name” 
 
 
• One cell to the right of the first accession number (B2), type  
“=VLOOKUP(A2,$E$1:$H$9, 2, FALSE)” 
 
o A1    the cell that contains what you’re searching for 
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o $E$1:$H$100   highlighting the entire table you’re taking 
information 
    from, with $ signs added to lock the entire thing 
in place  
    for when you start dragging it 
o 2   column number in the table you’re searching in 
containing  
    the information you’re looking for 
o FALSE  to tell it to search for a perfect match to the 
accession only 
• Copy this EXACT formula into cell under “Long Name”, but change column 2 
to column 4, in this example. 
 
• Drag down to fill in the remainder of the accessions from column A 
 
• Select all cells, then copy and “Paste Special” into same cells after clicking 
“Values” on the pop-up menu 
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• Delete reference table, leaving just the annotated original file.  
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APPENDIX II: RAW APE FILES USED FOR CHAPTER 2 
All primer sets here are labeled with the names used on the tubes as used in the 
laboratory. Primer titles were changed to a linear organization for chapter 2 to assist 
with cohesion of the work. No primer sequences were changed during this process. 
Below, the full genes with primer locations and sequencing locations are shown. The 
top bar on each represents the total length of the reference accession number.  
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